<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Glia</journal-id>
<journal-id journal-id-type="iso-abbrev">Glia</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)1098-1136</journal-id>
<journal-id journal-id-type="publisher-id">GLIA</journal-id>
<journal-title-group>
<journal-title>Glia</journal-title>
</journal-title-group>
<issn pub-type="ppub">0894-1491</issn>
<issn pub-type="epub">1098-1136</issn>
<publisher>
<publisher-name>John Wiley &amp; Sons, Inc.</publisher-name>
<publisher-loc>Hoboken, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31626379</article-id>
<article-id pub-id-type="pmc">6916335</article-id>
<article-id pub-id-type="doi">10.1002/glia.23730</article-id>
<article-id pub-id-type="publisher-id">GLIA23730</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Galectin‐3 modulates postnatal subventricular zone gliogenesis</article-title>
<alt-title alt-title-type="left-running-head">Al‐Dalahmah et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="glia23730-cr-0001">
<name>
<surname>Al‐Dalahmah</surname>
<given-names>Osama</given-names>
</name>
<xref ref-type="aff" rid="glia23730-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="glia23730-aff-0002">
<sup>2</sup>
</xref>
<address>
<email>osama.aldalahmah@gmail.com</email>
</address>
</contrib>
<contrib contrib-type="author" id="glia23730-cr-0002">
<name>
<surname>Campos Soares</surname>
<given-names>Luana</given-names>
</name>
<xref ref-type="aff" rid="glia23730-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="glia23730-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="glia23730-cr-0003">
<name>
<surname>Nicholson</surname>
<given-names>James</given-names>
</name>
<xref ref-type="aff" rid="glia23730-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="glia23730-cr-0004">
<name>
<surname>Draijer</surname>
<given-names>Swip</given-names>
</name>
<xref ref-type="aff" rid="glia23730-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="glia23730-cr-0005">
<name>
<surname>Mundim</surname>
<given-names>Mayara</given-names>
</name>
<xref ref-type="aff" rid="glia23730-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="glia23730-cr-0006">
<name>
<surname>Lu</surname>
<given-names>Victor M.</given-names>
</name>
<xref ref-type="aff" rid="glia23730-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="glia23730-cr-0007">
<name>
<surname>Sun</surname>
<given-names>Bin</given-names>
</name>
<xref ref-type="aff" rid="glia23730-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="glia23730-cr-0008">
<name>
<surname>Tyler</surname>
<given-names>Teadora</given-names>
</name>
<xref ref-type="aff" rid="glia23730-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="glia23730-cr-0009">
<name>
<surname>Adorján</surname>
<given-names>István</given-names>
</name>
<xref ref-type="aff" rid="glia23730-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="glia23730-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="glia23730-cr-0010">
<name>
<surname>O'Neill</surname>
<given-names>Eric</given-names>
</name>
<xref ref-type="aff" rid="glia23730-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="glia23730-cr-0011">
<name>
<surname>Szele</surname>
<given-names>Francis G.</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-2931-0673</contrib-id>
<xref ref-type="aff" rid="glia23730-aff-0001">
<sup>1</sup>
</xref>
<address>
<email>francis.szele@dpag.ox.ac.uk</email>
</address>
</contrib>
</contrib-group>
<aff id="glia23730-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Physiology, Anatomy and Genetics</named-content>
<institution>University of Oxford</institution>
<city>Oxford</city>
<country country="GB">UK</country>
</aff>
<aff id="glia23730-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Pathology and Cell Biology</named-content>
<institution>Columbia University Medical Center</institution>
<city>New York</city>
<named-content content-type="country-part">New York</named-content>
</aff>
<aff id="glia23730-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Oncology</named-content>
<institution>University of Oxford</institution>
<city>Oxford</city>
<country country="GB">UK</country>
</aff>
<aff id="glia23730-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Anatomy, Histology and Embryology</named-content>
<institution>Semmelweis University</institution>
<city>Budapest</city>
<country country="HU">Hungary</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Francis G. Szele, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK.<break></break>
Email: <email>francis.szele@dpag.ox.ac.uk</email><break></break>
Osama Al‐Dalahmah, Department of Pathology and Cell Biology, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY 10032.<break></break>
Email: <email>osama.aldalahmah@gmail.com</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2020</year>
</pub-date>
<volume>68</volume>
<issue>2</issue>
<issue-id pub-id-type="doi">10.1002/glia.v68.2</issue-id>
<fpage>435</fpage>
<lpage>450</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>5</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>18</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 Wiley Periodicals, Inc. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors. <italic>Glia</italic> published by Wiley Periodicals, Inc.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:GLIA-68-435.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Postnatal subventricular zone (SVZ) neural stem cells generate forebrain glia, namely astrocytes and oligodendrocytes. The cues necessary for this process are unclear, despite this phase of brain development being pivotal in forebrain gliogenesis. Galectin‐3 (Gal‐3) is increased in multiple brain pathologies and thereby regulates astrocyte proliferation and inflammation in injury. To study the function of Gal‐3 in inflammation and gliogenesis, we carried out functional studies in mouse. We overexpressed Gal‐3 with electroporation and using immunohistochemistry surprisingly found no inflammation in the healthy postnatal SVZ. This allowed investigation of inflammation‐independent effects of Gal‐3 on gliogenesis. Loss of Gal‐3 function via knockdown or conditional knockout reduced gliogenesis, whereas Gal‐3 overexpression increased it. Gal‐3 overexpression also increased the percentage of striatal astrocytes generated by the SVZ but decreased the percentage of oligodendrocytes. These novel findings were further elaborated with multiple analyses demonstrating that Gal‐3 binds to the bone morphogenetic protein receptor one alpha (BMPR1α) and increases bone morphogenetic protein (BMP) signaling. Conditional knockout of BMPR1α abolished the effect of Gal‐3 overexpression on gliogenesis. Gain‐of‐function of Gal‐3 is relevant in pathological conditions involving the human forebrain, which is particularly vulnerable to hypoxia/ischemia during perinatal gliogenesis. Hypoxic/ischemic injury induces astrogliosis, inflammation and cell death. We show that Gal‐3 immunoreactivity was increased in the perinatal human SVZ and striatum after hypoxia/ischemia. Our findings thus show a novel inflammation‐independent function for Gal‐3; it is necessary for gliogenesis and when increased in expression can induce astrogenesis via BMP signaling.</p>
</abstract>
<abstract abstract-type="graphical">
<title>Main points</title>
<p>
<list list-type="bullet"><list-item><p>Gal‐3 loss decreased SVZ‐striatal gliogenesis, whereas overexpression increased it.</p></list-item><list-item><p>Gal‐3 bound BMPr1‐α, increased BMP signaling and influenced glial fate choice.</p></list-item><list-item><p>Gal‐3 was increased in human perinatal hypoxia/ischemia.</p></list-item></list>
<boxed-text content-type="graphic" id="glia23730-blkfxd-0001" orientation="portrait" position="anchor"><graphic id="nlm-graphic-1" orientation="portrait" position="anchor" xlink:href="GLIA-68-435-g007.jpg"></graphic></boxed-text>
</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="glia23730-kwd-0001">electroporation</kwd>
<kwd id="glia23730-kwd-0002">galectin‐3</kwd>
<kwd id="glia23730-kwd-0003">gliogenesis</kwd>
<kwd id="glia23730-kwd-0004">subventricular zone</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-0001">
<funding-source>
<institution-wrap>
<institution>Biotechnology and Biological Sciences Research Council </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/501100000268</institution-id>
</institution-wrap>
</funding-source>
<award-id>BB/J018635/1</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="6"></fig-count>
<table-count count="0"></table-count>
<page-count count="16"></page-count>
<word-count count="11790"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>February 2020</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.3 mode:remove_FC converted:17.12.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="glia23730-cit-9001" publication-type="journal">
<string-name>
<surname>Al‐Dalahmah</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Campos Soares</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Nicholson</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Galectin‐3 modulates postnatal subventricular zone gliogenesis</article-title>. <source xml:lang="en"/>Glia. <year>2019</year>;<volume>68</volume>:<fpage>435</fpage>–<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1002/glia.23730</pub-id>
<pub-id pub-id-type="pmid">31626379</pub-id></mixed-citation>
</p>
<fn-group id="glia23730-ntgp-0001">
<fn id="glia23730-note-1002">
<p>
<bold>Funding information</bold> Biotechnology and Biological Sciences Research Council, Grant/Award Number: BB/J018635/1</p>
</fn>
</fn-group>
</notes>
</front>
<body id="glia23730-body-0001">
<sec id="glia23730-sec-0001">
<label>1</label>
<title>INTRODUCTION</title>
<p>Neural stem cells (NSCs) in the postnatal subventricular zone (pSVZ) give rise to neurogenic and gliogenic progenitors that produce olfactory bulb interneurons and forebrain glia, respectively (Levison &amp; Goldman, <xref ref-type="ref" rid="glia23730-bib-0028">1993</xref>; Lois &amp; Alvarez‐Buylla, <xref ref-type="ref" rid="glia23730-bib-0033">1994</xref>). Postnatal glial progenitors initially generate more astrocytes than oligodendrocytes, but this balance shifts in favor of the latter cells with increasing developmental age (Levison, Chuang, Abramson, &amp; Goldman, <xref ref-type="ref" rid="glia23730-bib-0027">1993</xref>). Both pSVZ‐derived astrocytes and oligodendrocytes populate forebrain parenchyma and white matter, and cells originating from the lateral pSVZ settle in the striatum (Tsai et al., <xref ref-type="ref" rid="glia23730-bib-0058">2012</xref>). Yet, the signaling cues that regulate rates of postnatal SVZ gliogenesis and fate choices are not fully understood.</p>
<p>Galectin‐3 (Gal‐3) binds N‐glycans on glycoproteins and glycolipids, forming cross‐linking oligomers (reviewed in [Dumic, Dabelic, &amp; Flogel, <xref ref-type="ref" rid="glia23730-bib-0013">2006</xref>; Liu &amp; Rabinovich, <xref ref-type="ref" rid="glia23730-bib-0032">2005</xref>]). Gal‐3 is mostly undetectable in the healthy brain and has few known constitutive roles. However, we showed it is uniquely expressed in the adult SVZ, even in the absence of injury, where it regulates neurogenesis by stimulating neuroblast migration (Comte et al., <xref ref-type="ref" rid="glia23730-bib-0011">2011</xref>). Gal‐3 is usually upregulated in brain injury, inflammation and cancer (Liu &amp; Rabinovich, <xref ref-type="ref" rid="glia23730-bib-0032">2005</xref>), promoting parenchymal astrocytic proliferation, microglial activation, angiogenesis, and immune cell influx into the SVZ (James et al., <xref ref-type="ref" rid="glia23730-bib-0024">2016</xref>; Lalancette‐Hebert et al., <xref ref-type="ref" rid="glia23730-bib-0026">2012</xref>; Sirko et al., <xref ref-type="ref" rid="glia23730-bib-0054">2015</xref>; C. C. Young et al., <xref ref-type="ref" rid="glia23730-bib-0061">2014</xref>). Other evidence has suggested Gal‐3 regulates oligodendrocyte differentiation in the adult (Pasquini et al., <xref ref-type="ref" rid="glia23730-bib-0049">2011</xref>). Disentangling constitutive effects of Gal‐3 from those of accompanying injury and inflammation has seldom been attempted. Here we found that artificially increasing SVZ Gal‐3 expression in healthy mice did not induce inflammation. Thus, we were able to distinguish Gal‐3 functions in the pSVZ from those associated with inflammation and injury, and found that it is sufficient to stimulate pSVZ gliogenesis.</p>
<p>Molecular studies have shown that Gal‐3 regulates several important developmental signaling pathways such as those mediated by the wingless‐related integration site (Wnt), Notch and epidermal growth factor receptor (EGFR) (Nakajima et al., <xref ref-type="ref" rid="glia23730-bib-0046">2014</xref>; Partridge et al., <xref ref-type="ref" rid="glia23730-bib-0048">2004</xref>; Song et al., <xref ref-type="ref" rid="glia23730-bib-0055">2009</xref>), but its effect on other pathways such as bone morphogenetic protein (BMP) signaling was unknown. BMP signaling peaks early postnatally and declines in adulthood (Mehler, Mabie, Zhang, &amp; Kessler, <xref ref-type="ref" rid="glia23730-bib-0037">1997</xref>). BMP receptor activation inhibits proliferation and suppresses SVZ neurogenesis while promoting gliogenesis (Lim et al., <xref ref-type="ref" rid="glia23730-bib-0031">2000</xref>). Several groups have further shown that BMP suppresses oligodendrogenesis while promoting astrogenesis (Gomes, Mehler, &amp; Kessler, <xref ref-type="ref" rid="glia23730-bib-0018">2003</xref>; Mabie et al., <xref ref-type="ref" rid="glia23730-bib-0035">1997</xref>; Morell, Tsan, &amp; O'Shea, <xref ref-type="ref" rid="glia23730-bib-0044">2014</xref>). Other data suggest BMP suppresses the oligodendrocytic fate but has a permissive effect on olfactory bulb neurogenesis (Colak et al., <xref ref-type="ref" rid="glia23730-bib-0009">2008</xref>). Since Gal‐3 binds to multiple targets, influences gliogenesis in vitro and is expressed in the SVZ (Comte et al., <xref ref-type="ref" rid="glia23730-bib-0011">2011</xref>; Liu &amp; Rabinovich, <xref ref-type="ref" rid="glia23730-bib-0032">2005</xref>) we reasoned it may regulate BMP signaling.</p>
<p>Human perinatal hypoxic/ischemic injury (H/I) is relatively common (Rivkin &amp; Volpe, <xref ref-type="ref" rid="glia23730-bib-0051">1993</xref>) and can result in devastating consequences such as cerebral palsy. Periventricular regions are particularly vulnerable to H/I and the SVZ stem cell niche, which lines the lateral ventricles is likely involved in H/I‐induced abnormal gliogenesis. Understanding molecular events caused by H/I is necessary for developing therapeutic approaches, which are currently limited. A central problem in understanding molecular signals in human perinatal H/I is the scarcity of tissue specimens from postmortem neonates with H/I and the difficulty in obtaining them. Well‐matched control samples are even more rare. Another major hurdle in understanding H/I‐induced molecular cascades is the complex milieu of secondary inflammatory mediators and cellular debris that accompany cell death (Oyarce &amp; Iturriaga, <xref ref-type="ref" rid="glia23730-bib-0047">2018</xref>). These confounding factors make it difficult to ascertain whether such molecular events are secondary to hypoxia, subsequent inflammation, or both. Here, we found that Gal‐3 is increased in the periventricular SVZ and striatum (caudate nucleus) in postmortem brain sections from human neonates with H/I.</p>
<p>In this study, we specifically focused on the postnatal lateral SVZ (plSVZ) since it comprises the majority of the niche. In addition, the dorsal, lateral, and ventral SVZ can harbor distinct signaling pathways and lineages and therefore should be studied separately (Azim et al., <xref ref-type="ref" rid="glia23730-bib-0004">2014</xref>; Fiorelli, Azim, Fischer, &amp; Raineteau, <xref ref-type="ref" rid="glia23730-bib-0015">2015</xref>). We decreased and increased Gal‐3 expression via in vivo electroporation and in vitro nucleofection and interrogated BMP signaling. We found that Gal‐3 binds to the bone morphogenetic protein receptor one alpha (BMPR1α), activates BMP signaling in the plSVZ and influences the balance of plSVZ astrogenesis versus oligodendrogenesis. Using transgenic BMPR1α<sup>fl/fl</sup> mice, we showed that Gal‐3 mediates its gliogenic effects through BMPR1α signaling. Finally, we demonstrated that Gal‐3 is increased in human perinatal H/I‐induced brain injury. Overall, our work demonstrates novel roles for Gal‐3 in regulating postnatal SVZ striatal gliogenesis.</p>
</sec>
<sec id="glia23730-sec-0002">
<label>2</label>
<title>MATERIALS AND METHODS</title>
<sec id="glia23730-sec-0003">
<label>2.1</label>
<title>Animals</title>
<p>C57BL/6‐Tg (BMPR1α‐fx, R26R‐YFP) mice, referred to as BMPR1α<sup>fl/fl</sup> were a kind gift from Dr. Tristan Rodriguez and are described elsewhere (Mishina, Hanks, Miura, Tallquist, &amp; Behringer, <xref ref-type="ref" rid="glia23730-bib-0041">2002</xref>; Srinivas et al., <xref ref-type="ref" rid="glia23730-bib-0056">2001</xref>). C57BL/6, Gal‐3<sup>fl/fl</sup>, or BMPR1α<sup>fl/fl</sup> mice were used for in vivo electroporation, and CD1 or C57BL/6 mice for in vitro neurosphere culture, nucleofection, western blotting, and protein co‐immunoprecipitation. Both CD1 and C57BL/6 mice were purchased from Harlan UK (Oxon, United Kingdom). Gal‐3<sup>fl/fl</sup> mice (B6NTac; B6N‐Lgals3tm1a[EUCOMM]Wtsi/H), were obtained from the International Mouse Phenotyping Consortium/MRC Harwell. All animal procedures were carried out with Oxford University Research Ethics Committee approval in accordance with the Animals (Scientific Procedures) Act of 1986 (UK).</p>
</sec>
<sec id="glia23730-sec-0004">
<label>2.2</label>
<title>Human subjects</title>
<p>To study the effect of H/I on Gal‐3 expression in the SVZ and striatum, we selected subjects with minimal hypoxia (<italic>n</italic> = 2) from a former study (Adorjan et al., <xref ref-type="ref" rid="glia23730-bib-0002">2019</xref>) and subjects with more pronounced H/I (<italic>n</italic> = 12) from the Oxford Brain Bank (OBB) (Table <xref ref-type="supplementary-material" rid="glia23730-supitem-0001">S1</xref>). A further <italic>n</italic> = 7 subjects were selected from the OBB for study of the cerebral cortex. All human material was collected from donors from whom written informed consent had been obtained by the OBB for brain autopsy and use of material and clinical information for research purposes. Based on neuropathological analysis of hypoxic insults in the CNS and information on clinical history we stratified the perinatal cohort into four hypoxia groups with different duration of hypoxia (minimal&lt;1 day, acute 1–2 days, subacute 3–4 days and chronic &gt;4 days). The demographic characteristics of the cohort are shown in Table <xref ref-type="supplementary-material" rid="glia23730-supitem-0001">S1</xref>. Prenatal ages were described using gestational weeks (last menstruation before pregnancy).</p>
</sec>
<sec id="glia23730-sec-0005">
<label>2.3</label>
<title>Plasmids and cloning</title>
<p>pCAGIG (pCAG‐IRES‐GFP) was a gift from Dr. Connie Cepko (Addgene plasmid # 11159) (Matsuda &amp; Cepko, <xref ref-type="ref" rid="glia23730-bib-0036">2004</xref>). pCAG‐Cre‐IRES2‐GFP (Addgene plasmid # 26646) (Woodhead, Mutch, Olson, &amp; Chenn, <xref ref-type="ref" rid="glia23730-bib-0059">2006</xref>) and pTOP‐dGFP‐CAG‐mCherry (Mutch, Funatsu, Monuki, &amp; Chenn, <xref ref-type="ref" rid="glia23730-bib-0045">2009</xref>) were gifts from Dr. Anjen Chenn. pGL3‐BRE‐Luciferase was a gift from Dr. Martine Roussel and Dr. Peter ten Dijke (Addgene plasmid # 45126) (Korchynskyi &amp; ten Dijke, <xref ref-type="ref" rid="glia23730-bib-0025">2002</xref>). pGL4.75 (hRluc/CMV) plasmid (GenBank: AY738231, Promega) was a gift from Dr. Ian Tomlinson. pSilencer 2.0‐U6 (Ambion CAT #AM7209) containing a non‐targeting sequence (shNT) was a gift from Dr. Jo Begbie. pCS‐TdTomato‐m2A was a gift for Dr. Shankar Srinivas. Gal‐3 cDNA (NM_010705) was PCR amplified from SVZ‐derived cDNA, and Sanger sequencing confirmed the sequence. All SNP's were found to be synonymous. The sequence was cloned into pCAGIG to give rise to pCAG‐Gal‐3‐IRES‐GFP plasmid. The plasmid was digested to remove the IRES site and GFP and then ligated to give rise to pCAG‐Gal‐3 plasmid. Validated Gal‐3 short‐hairpin sequences (Henderson et al., <xref ref-type="ref" rid="glia23730-bib-0020">2006</xref>) were cloned into pSilencer 2.0‐U6 vector to produce 4 shGal‐3 plasmids. The plasmids were tested in vitro and in vivo for knockdown efficiency, and the most efficient sequence; GATGTTGCCTTCCACTTTA, was used for subsequent experiments.</p>
</sec>
<sec id="glia23730-sec-0006">
<label>2.4</label>
<title>In vivo brain electroporation</title>
<p>Electroporation was performed as in (Boutin, Diestel, Desoeuvre, Tiveron, &amp; Cremer, <xref ref-type="ref" rid="glia23730-bib-0007">2008</xref>; Sun, Chang, Gerhartl, &amp; Szele, <xref ref-type="ref" rid="glia23730-bib-0057">2018</xref>). Briefly, P2 pups were anesthetized by hypothermia. Then, 1–2 μl of plasmid(s) solution (2 μg/μl per plasmid with 0.1% Fast Green in Endotoxin‐free TE, Qiagen) was injected into the right lateral ventricle of C57BL6 or Gal‐3<sup>fl/fl</sup> or BMPR1α<sup>fl/fl</sup> mice. Electroporation was carried out with five 50‐ms 100 V pulses with 850 ms intervals, using CUY650‐P5 tweezers (Sonidel) connected to an ECM830 square wave electroporator (BTX). Pups recovered in a 36°C heating chamber for 15–20 min and then returned to the dam. Mice were perfused 3, 7, or 17 DPE. The electroporation efficiency was consistent and reproducible between animals, and we found that 7.8 ± 1.9% of DAPI+ SVZ cells were electroporated, N = 3, 3DPE.</p>
</sec>
<sec id="glia23730-sec-0007">
<label>2.5</label>
<title>Thymidine analog injection</title>
<p>BrdU (Sigma Aldrich) and EdU (Life Technologies) were reconstituted in sterile normal saline at 10 mg/ml. A single intraperitoneal (i.p.) injection of BrdU or EdU (50 mg/kg) was given.</p>
</sec>
<sec id="glia23730-sec-0008">
<label>2.6</label>
<title>Histology and fluorescent immunohistochemistry</title>
<p>Mice were perfused with normal saline then 4% paraformaldehyde (PFA), brains extracted, postfixed in 4% PFA, cryoprotected in 30% sucrose, frozen, and sectioned in the coronal plane on a sliding microtome. We used standard free‐floating immunohistochemistry. Briefly, 5–6 sections/animal were washed with 0.1 M PBS 3 × 10 min, incubated in 50 mM glycine in PBS for 15 min, washed with 0.1 M PBS 3 × 10 min, blocked for 1 hr in PBS + 10% Donkey Serum+0.1% Triton X‐100, before primary antibody (Ab) incubation overnight at 4°C. Three PBS washes preceded and followed incubation in secondary Ab for 1 hr at RT. DAPI (Sigma) was used to stain nuclei before section mounting and coverslipping. For BrdU and p27Kip1 detection initial an antigen retrieval step (2 N HCl for 1 hr at 37°C) was used. Human histology: coronal sections (6 μm thick) were cut from paraffin‐embedded blocks and mounted on slides. Immunohistochemical analysis was done as described in detail (Adorjan et al., <xref ref-type="ref" rid="glia23730-bib-0001">2017</xref>). Briefly, anti‐Galectin‐3 antibody (Abcam, ab 2,785, 1:200, mouse, monoclonal) was applied following heat‐induced antigen retrieval in a 121°C autoclave for 10 min in EDTA (pH = 9.0) and revealed with 3,3′‐Diaminobenzidine (DAB).</p>
<p>The following primary Ab's were used: chicken α‐GFP (1:500; Avislabs), rabbit α‐Mcherry (1:750; Abcam), rabbit α‐Ki67 (1:500; Abcam), rabbit α‐S100β (1:200; Dako), mouse α‐vimentin (1:100; DSHB), rabbit α‐Caspase‐3 (1:500; Cell Signaling), rabbit α‐Smad 1/5/8 (1:500; Cell Signaling), rabbit α‐pSmad1/5 (Ser463/465) (1:500; Cell Signaling), rat α‐GFAP (1:500; Invitrogen), goat α‐Dcx (1:100; Santa‐Cruz), rat α‐Galectin‐3 (1:100; Santa‐Cruz), rat α‐BrdU (1:600; Novus Biologicals), rat α‐CD45 (1:400; Millipore), rabbit α‐Olig2 (1:1000; Millipore), mouse α‐NeuN (1:400; Millipore), goat α‐Iba1 (1,300; Abcam), rabbit α‐β‐catenin (1,1000; Sigma), mouse α‐Mash1 (Ascl1) (1,100; BD Biosciences). Secondary antibodies conjugated to Alexa Fluor 488, 568, 594, or 647 (Invitrogen, Sigma and Jackson Laboratory) were used as appropriate. For EdU detection, a Click‐iT® EdU detection kit (Invitrogen) was used and the manufacturer's protocol adapted to free‐floating IHC. Standard LacZ histochemistry was carried out (Jackson Laboratory website).</p>
</sec>
<sec id="glia23730-sec-0009">
<label>2.7</label>
<title>Image acquisition and quantification</title>
<p>Confocal images were acquired on a Zeiss LSM 710 microscope. All images represent single optical planes, unless noted. All quantifications were done by an observer blinded to experimental condition. For co‐localization studies, 40X <italic>Z</italic>‐stacks and 20X <italic>Z</italic>‐stacks (12 optical sections, each 1.3 μm apart) were quantified with Volocity 6.3 (Improvision) and ImageJ. At least three images from three sections were quantified per animal and considered technical replicates. The sections spanned the lateral ventricle (LV) at the level of, and anterior to, the crossing of the anterior commissure. Quantifications were done in the lateral SVZ only, and the dorsolateral horn of the SVZ was excluded. Only DAPI+ cells were included, and cells the nuclei of which were not completely within the z‐stack were excluded.</p>
</sec>
<sec id="glia23730-sec-0010">
<label>2.8</label>
<title>Protein extraction, immunoprecipitation, and western blotting</title>
<p>Dissected SVZ tissue was lysed in Triton X‐100 lysis buffer (1% Triton‐X‐100, 150 mM NaCl, 50 mM Tris HCl pH 8.0, Roche Complete protease inhibitor cocktail). HEK293T cells were seeded into 6‐well plates (200,000 cells/well) in 2 ml of growth media (DMEM +10% Fetal Bovine Serum +100 I.U/ml Penicillin G and 100 mg/ml Streptomycin) 24 hr before transfection. The following day, cells achieved 70% confluence, which is suitable for transfection. One hour prior to transfection, the media was changed to Opti‐MEM® (Life Technologies). Then, 2.0 μg of plasmid DNA (pCAG‐Gal‐3‐IRES‐GFP and pCMV3‐SP‐HA‐BMPR2 (Sino Biological) and/or pCMV3‐mBMPR1α‐Flag (Sino Biological)) was used with Lipofectamine 3,000™ (Life Technologies) for transfection according to manufacturer's protocol. The media was changed to growth media with 20% FBS 12 hr post transfection, and transfection efficiency (70–80%) was verified using GFP fluorescence. The cells were harvested for protein 48 hr post‐transfection. Immunoprecipitation (IP) was performed using μMACS™ protein A/G microBead magnetic separation (Miltenyi Biotec 130–071‐001) according to the manufacturer's manual. Briefly, 200 μg of protein, 1 μg of monoclonal antibody (mouse anti‐Octa probe (H5); Santa Cruz sc‐166355, mouse anti‐HA F‐7; Santa Cruz sc‐7392, rat anti‐Gal‐3 (M3/38); Santa Cruz sc‐23938, or 2 μg of control polyclonal antibody, and 50 μl of protein G microbeads (Miltenyi Biotec) were mixed by vortexing and incubated for 30 min on ice. The magnetically labeled lysate was passed through a MACS μcolumn placed in a magnetic field. The columns were washed and the elution followed. The eluent protein was then electrophoresed on NuPage BT 4–12% gels for western blot analysis. Immunoblotting for Gal‐3 (rabbit anti‐Gal‐3 [H‐160]; Santa Cruz sc‐20157) FLAG (mouse anti‐Octa probe (H5); Santa Cruz sc‐166355, or rabbit anti‐DYKDDDDK Tag; CS‐2368), or BMPR1α (Rabbit anti‐BMPR1α, Invitrogen 38‐6000) was followed by visualization on a LiCOR Odyssey system after blotting with appropriate IRDye‐fluorescent secondary antibodies.</p>
</sec>
<sec id="glia23730-sec-0011">
<label>2.9</label>
<title>Statistical analyses</title>
<p>All mouse quantification was done blind to experimental condition using a random coding system. Differences between two groups were assessed using unpaired <italic>t</italic>‐test when normality could be checked using Shapiro–Wilk test (<italic>n</italic> = 5 or more) or the Mann–Whitney U nonparametric test (<italic>n</italic> = 3 or 4). For in vitro experiments, including qPCR analysis of delta–delta Ct values from biological replicates, one sample <italic>t</italic>‐test was used after data normalization to control. Comparisons between three or more groups were conducted using analysis of variance (ANOVA) with Tukey or Sidak post hoc tests as appropriate in experiments with <italic>n</italic> ≥ 5, otherwise, the Kruskal Wallis test was used, unless otherwise indicated. For analysis of human Gal‐3+ cells, a one tailed <italic>t</italic>‐test (samples with unequal variance) was used in Excel to compare the percentage of strongly Gal‐3+ cells among all cells counted by a standardized algorithm (Supporting materials and methods). Significance is indicated as follows: *<italic>p</italic> &lt; .05, **<italic>p</italic> &lt; .01, ***<italic>p</italic> &lt; .001, ****<italic>p</italic> &lt; .0001. Values were presented as mean ± <italic>SEM</italic>, unless otherwise indicated. Analyses and graphical representations were performed in Microsoft Excel 2011 and GraphPad Prism 6 (GraphPad) software packages. All other methods are described in Supplementary Materials and methods.</p>
</sec>
</sec>
<sec id="glia23730-sec-0012">
<label>3</label>
<title>RESULTS</title>
<sec id="glia23730-sec-0013">
<label>3.1</label>
<title>Galectin‐3 does not induce inflammation or apoptosis in the postnatal SVZ</title>
<p>We have previously shown that most SVZ cells except for neuroblasts constitutively express Gal‐3 in the postnatal and adult niche (Comte et al., <xref ref-type="ref" rid="glia23730-bib-0011">2011</xref>; Hillis, Davies, Mundim, Al‐Dalahmah, &amp; Szele, <xref ref-type="ref" rid="glia23730-bib-0021">2016</xref>; James et al., <xref ref-type="ref" rid="glia23730-bib-0024">2016</xref>; C. C. Young et al., <xref ref-type="ref" rid="glia23730-bib-0061">2014</xref>). We found the same pattern of expression in the pSVZ in this study (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0002">S1</xref>). We used immunohistochemistry for glial fibrillary acidic protein (GFAP) to label SVZ astrocytes (a subset of which are NSCs), Mash1 (Ascl1) to label transit amplifying progenitors, and doublecortin (Dcx) to label neuroblasts (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0002">S1</xref>). Gal‐3 was expressed by a subset of GFAP+ and Mash1+ SVZ cells but was not detectable in Dcx+ neuroblasts.</p>
<p>We next validated Gal‐3 knockdown and overexpression constructs in vitro and in vivo (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0003">S2</xref>a). Three days after transfection of HEK293T cells, western blotting was used to compare Gal‐3 protein levels between different combinations of GFP expressing control plasmids, Gal‐3 overexpression, Gal‐3 knockdown and non‐targeting shRNA (shNT) control. The OE plasmid increased Gal‐3 levels from baseline and 4 shGal‐3 plasmids (V1‐4) knocked down Gal‐3 after OE (baseline levels of Gal‐3 were very low in HEK293T cells, Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0003">S2</xref>a). V1 was most efficient (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0003">S2</xref>a) and we used it throughout the study unless otherwise specified. We next examined the effects on Gal‐3 expression of these constructs in vivo by co‐electroporating them with a plasmid expressing mCherry into the plSVZ of P2 mice, as in (Sun et al., <xref ref-type="ref" rid="glia23730-bib-0057">2018</xref>). Quantitative comparison of Gal‐3 immunofluorescence with mCherry showed that already at 3 days post electroporation (3DPE) of shGal‐3, Gal‐3 immunofluorescence was significantly decreased in SVZ cells (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0003">S2</xref>b,c). Conversely, Gal‐3 OE significantly increased Gal‐3 immunofluorescence (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0003">S2</xref>b,c). Gal‐3 knockdown was next assessed in vivo at 17DPE with co‐electroporation of a tdTomato expressing plasmid. The percentage of tdTomato positive cells that exhibited Gal‐3 immunofluorescence was significantly reduced by the V1 and V2 shGal3 constructs (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0003">S2</xref>d,e).</p>
<p>Inflammation and injury are associated with elevated Gal‐3 (James et al., <xref ref-type="ref" rid="glia23730-bib-0024">2016</xref>; Y. Li et al., <xref ref-type="ref" rid="glia23730-bib-0030">2008</xref>; Lopez et al., <xref ref-type="ref" rid="glia23730-bib-0034">2006</xref>) and inflammation affects gliogenesis, neurogenesis, and proliferation in neural stem cell niches (Ekdahl, Claasen, Bonde, Kokaia, &amp; Lindvall, <xref ref-type="ref" rid="glia23730-bib-0014">2003</xref>; Monje, Toda, &amp; Palmer, <xref ref-type="ref" rid="glia23730-bib-0043">2003</xref>; Ribeiro Xavier, Kress, Goldman, Lacerda de Menezes, &amp; Nedergaard, <xref ref-type="ref" rid="glia23730-bib-0050">2015</xref>; Shigemoto‐Mogami, Hoshikawa, Goldman, Sekino, &amp; Sato, <xref ref-type="ref" rid="glia23730-bib-0053">2014</xref>). Since Gal‐3 modulates inflammation and levels of Gal‐3 are increased in inflammatory conditions, it is difficult to distinguish if effects of increased Gal‐3 are primary or secondary to inflammation. To study Gal‐3's effect on plSVZ cellular inflammation, we used antibodies against CD45, a pan‐immune cell marker (Goings, Kozlowski, &amp; Szele, <xref ref-type="ref" rid="glia23730-bib-0017">2006</xref>). We qualitatively assessed CD45+ cells blind to the treatment and found that microglial morphology and numbers were unchanged in the plSVZ upon Gal‐3 OE at 3, 7, and 17DPE (Figures <xref ref-type="fig" rid="glia23730-fig-0001">1</xref>a,b and <xref ref-type="supplementary-material" rid="glia23730-supitem-0004">S3</xref>a). Iba1 immunohistochemistry was next used to examine microglial cells that were potentially activated by Gal‐3 OE. Analysis at 3, 7, and 17 DPE showed that Iba1+ cell density per volume was unchanged by Gal‐3 OE in the SVZ as well as in the striatum (Figures <xref ref-type="fig" rid="glia23730-fig-0001">1</xref>c,d and <xref ref-type="supplementary-material" rid="glia23730-supitem-0004">S3</xref>b,c). A detailed morphological analysis of Iba1+ microglia revealed that most were in an intermediate state of activation at all three ages examined (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0004">S3</xref>c,d). Gal‐3 OE also did not change the level of microglial morphological activation in the SVZ or in the striatum at 3, 7, and 17DPE (Figures <xref ref-type="fig" rid="glia23730-fig-0001">1</xref>d and <xref ref-type="supplementary-material" rid="glia23730-supitem-0004">S3</xref>c,d).</p>
<fig fig-type="Figure" id="glia23730-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Gal‐3 did not induce inflammation in the absence of injury. (a) Plasmids used and timeline of in vivo brain electroporation. (b) Representative confocal collapsed stacks of control and Gal‐3 OE 3DPE showing DAPI+ nuclei (blue), electroporated GFP+ cells (green), and CD45+ immunohistochemistry (red). LV, lateral ventricle. Scale bar: 20 μm. (c) Representative sections stained for Iba1 and DAPI, 7 and 17DPE. The SVZ is delineated with white lines. STR, striatum. Scale bar: 30 μm. (d) Quantification of Iba1+ microglial density/mm<sup>3</sup> and activation status as resting (Rest), intermediate (Inter), activated (Act) in the SVZ, and striatum (STR). <italic>n</italic> = 3–4. (e) Representative confocal images at 17DPE; electroporated GFP+ cells (green), A.Casp3 (red), and DAPI+ nuclei (blue) from control and Gal‐3 OE. The arrow indicates a GFP+ A.Casp3+ cell, whereas the arrowhead indicates a GFP‐A.Casp3+ cell. Orthogonal views of the indicated cells are shown on the left. Scale bars: 10 μm. (f) Quantification of the mean number of Caspase3+ cells per animal at 7 and 17 DPE. Statistical significance was determined using Mann–Whitney test. Data are shown as mean ± <italic>SEM</italic>. *<italic>p</italic> &lt; .05. Gal‐3, Galectin‐3; ns, nonsignificant; SVZ, subventricular zone</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="GLIA-68-435-g001"></graphic>
</fig>
<p>Inflammation can cause apoptosis, thus we examined a marker of apoptosis, activated Caspase‐3+ (Alfonso‐Loeches, Pascual‐Lucas, Blanco, Sanchez‐Vera, &amp; Guerri, <xref ref-type="ref" rid="glia23730-bib-0003">2010</xref>). Gal‐3 OE did not change the number of electroporated SVZ cells expressing activated Caspase‐3 at 7 or 17DPE (Figure <xref ref-type="fig" rid="glia23730-fig-0001">1</xref>e,f). Similarly, quantification showed that the number of Caspase‐3 cells in the OB 7DPE was unchanged in the OE group compared to controls (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0004">S3</xref>e). Moreover, we found no evidence of an increase in electroporated cells that co‐labeled with A.Caspase 3 or A.Caspase 3 and Olig2 at 3DPE (Data not shown). This suggests that Gal‐3 did not affect programmed cell death, that Gal‐3 OE did not elicit an inflammatory response in the plSVZ, and that Gal‐3 effects on the SVZ are independent of microglial inflammation.</p>
</sec>
<sec id="glia23730-sec-0014">
<label>3.2</label>
<title>Gal‐3 is necessary and sufficient for striatal gliogenesis</title>
<p>The large majority of postnatal SVZ progenitors that migrate into the striatum differentiate into glia, as opposed to neurons (Levison et al., <xref ref-type="ref" rid="glia23730-bib-0027">1993</xref>; Levison &amp; Goldman, <xref ref-type="ref" rid="glia23730-bib-0028">1993</xref>). We categorized striatal GFP+ cells as astrocytes, oligodendrocytes, or others/undetermined using established morphological criteria and approximately 99% of GFP+ cells in the striatum were classified as glia (Supplementary materials and methods). Using these criteria, the large majority of cells morphologically classified as astrocytes or oligodendrocytes expressed GFAP/S100β and Olig2, respectively (Figure <xref ref-type="fig" rid="glia23730-fig-0002">2</xref>a). To study Gal‐3's effects on this process, we altered Gal‐3 levels in the SVZ at P2 and harvested brains at P19 giving sufficient time for gliogenesis (Figure <xref ref-type="fig" rid="glia23730-fig-0002">2</xref>a). To determine if Gal‐3 is necessary for striatal gliogenesis, we first electroporated Gal‐3 KD constructs into the P2 SVZ (Figure <xref ref-type="fig" rid="glia23730-fig-0002">2</xref>b,c). In order to compensate for slight variations in electroporation efficiency, we determined what percentage of total GFP+ cells (SVZ + striatum) where found in the striatum. This percentage was statistically significantly decreased after Gal‐3 knockdown indicating that Gal‐3 is necessary for gliogenesis (Figure <xref ref-type="fig" rid="glia23730-fig-0002">2</xref>d). We next confirmed the Gal‐3 knockdown effect with Gal‐3<sup>fl/fl</sup> mice (Figures <xref ref-type="fig" rid="glia23730-fig-0002">2</xref>e–f and <xref ref-type="supplementary-material" rid="glia23730-supitem-0003">S2</xref>f–j). We first showed statistically significant loss of Gal‐3 expression in the SVZ of animals electroporated with GPF‐Cre compared to control GFP plasmids (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0003">S2</xref>i,j) (17DPE, <italic>n</italic> = 3 mice/group, ~70 cells/mouse quantified). Compared with control GFP plasmid electroporation, Cre‐electroporated Gal‐3<sup>fl/fl</sup> mice had a significantly smaller percentage of total GFP+ glial cells in the striatum at 17DPE (Figure <xref ref-type="fig" rid="glia23730-fig-0002">2</xref>f,g). Double labeling with GFAP and Olig2 antibodies confirmed that GFP+ cells in the striatum were positive for either one or the other glial marker, confirming SVZ—striatal gliogenesis (Figure <xref ref-type="fig" rid="glia23730-fig-0002">2</xref>f). These data show that endogenous Gal‐3 is overall necessary for striatal gliogenesis from the plSVZ, revealing a novel constitutive neurodevelopmental function for this protein.</p>
<fig fig-type="Figure" id="glia23730-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>Gal‐3 loss‐of‐function regulates gliogenesis. (a) The morphological criteria used to classify GFP+ cells as oligodendrocytes or astrocytes largely matched marker expression. The top left panel shows a GFAP+ astrocyte‐like cell, an Olig2+ oligodendrocyte‐like cell and an undetermined cell. Note that GFP and glial marker double labeling appears white in the merged images. Bottom left panel shows example of a GFP + GFAP+ astrocyte (arrow) that is negative for Olig2. Scale bars = 30 μm. (b) Plasmids, mice, and design of Gal‐3 knockdown in vivo loss‐of‐function electroporation. (c) Representative confocal images of GFP+ cells 17DPE of control and knockdown constructs. The white lines demarcate the SVZ. Scale bar: 30 μm. (d) Quantification of B as percent of SVZ + striatal GFP+ cells that are striatal. (e) Plasmids, mice, and design of Gal‐3 conditional knockout in vivo loss‐of‐function electroporation. (f) Representative confocal images of GFP+, GFAP+, Olig2+ cells, and DAPI+ nuclei. 17DPE with control or Cre‐plasmids. The white line demarcates the lateral ventricle. Scale bar: 15 μm. (g) Quantification of E as percent of SVZ + striatal GFP+ cells that are striatal. Statistical significances were calculated using Mann–Whitney <italic>U</italic> tests. <italic>n</italic> = 3–4 mice/group. Gal‐3, Galectin‐3; SVZ, subventricular zone</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="GLIA-68-435-g002"></graphic>
</fig>
<p>Contrary to the loss‐of‐function effects, Gal‐3 OE in WT mice significantly increased the proportion of GFP+ glial cells in the striatum at 17DPE (Figure <xref ref-type="fig" rid="glia23730-fig-0003">3</xref>a–c). Increased striatal gliogenesis occurred without alteration in the total number of electroporated cells, the rate of SVZ proliferation, the percent of astrocytes or the percent of proliferative astrocytes at 17DPE (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0005">S4</xref>a–e).</p>
<fig fig-type="Figure" id="glia23730-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<p>Gal‐3 gain‐of‐function regulates gliogenesis. (a) Plasmids, mice and design of Gal‐3 OE in vivo gain‐of‐function electroporation. (b) Confocal images including SVZ and striatum (STR). DAPI+ nuclei, GFP+, and GFAP+ cells shown. (c) Quantification of H as percent of SVZ + striatal GFP+ cells that are striatal. (d) Projection images showing DAPI+ nuclei, GFAP+, GFP+ and S100β + cells in controls and Gal‐3 OE. White arrows indicate GFP+GFAP+S100β + cells, the yellow arrows GFP+GFAP+S100β‐ cell, and arrowheads GFP+GFAP‐S100β− cell in the STR. (e) Single confocal planes showing DAPI+ nuclei, GFP+, and Olig2+ cells. Arrowheads point to GFP+Olig2‐ cells and the arrow to a GFP+Olig2+ cell. (d, e) Boxed areas shown as magnified and orthogonal views on the left. (f) Quantification of D as percent of striatal GFP+ cells that are GFAP+ or S100β+. G: Quantification of E as percent of striatal GFP+ cells that are Olig2+. Scale bar for B: 200 μm. Scale bars for D, E: 20 μm for main panels, 10 μm for insets. Statistical significances were calculated using Mann–Whitney U tests. <italic>n</italic> = 3–4 mice/group. Gal‐3, Galectin‐3; SVZ, subventricular zone</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="GLIA-68-435-g003"></graphic>
</fig>
<p>We next looked at the earlier survival time of 7DPE and similar to 17DPE, Gal‐3 OE did not affect SVZ proliferation, the number of label‐retaining cells or cell cycle re‐entry (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0006">S5</xref>a‐e). At 7DPE, Gal‐3 OE also did not increase the percent of GFP+ cells that expressed Ki67 (Ki67 labeling index) or the percent of GFP+ cells that expressed GFAP (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0006">S5</xref>f–h). However, Gal‐3 OE did increase the number of electroporated GFP+ cells that were GFAP+Ki67+ (Ki67 GFAP+ labeling index) in the SVZ (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0006">S5</xref>f,i). Ki67 labels multiple phases of the cell cycle and thus the effect could have been due to prolonged phases of the cell cycle, rather than increased proliferation. Contrary to the Ki67 labeling index, which measures the growth fraction and is influenced by changes in cell‐cycle length, the M‐phase of the cell‐cycle labeled by Phi3 is relatively stable. Thus, changes in the Phi3 labeling index would reflect changes in proliferation rather than cell‐cycle length. We therefore determined whether Gal‐3 OE increases Phi3 at 7 DPE in GFAP+GFP+ cells. We found that similar to Ki67, the percent of GFP+ cells that were Phi3+ was unchanged by Gal‐3 OE (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0006">S5</xref>l). Also, similar to Ki67, the percent of GFAP+GFP+ cells that expressed Phi3 was significantly increased by Gal‐3 OE (<italic>p</italic> = .032 – one‐tailed <italic>t</italic>‐test) (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0006">5Sk</xref>). In contrast to its effects on striatal gliogenesis, we found no evidence that Gal‐3 OE has an effect on olfactory bulb neurogenesis at 17DPE (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0007">S6</xref>a–e). Together, these data show that Gal‐3 OE selectively increases the Ki67 and Phi3 labeling indices (and therefore overall proliferation) of a subset of SVZ GFAP+ cells without altering olfactory bulb neurogenesis or NSC activation (Supplementary results).</p>
<p>We noticed after Gal‐3 OE in the SVZ that many striatal GFP+ cells had altered morphology compared to controls (Figure <xref ref-type="fig" rid="glia23730-fig-0003">3</xref>b). To determine the astrocytic identity and differentiation state of electroporated cells, we examined GFAP and S100β expression (both mature astrocyte markers, Figure <xref ref-type="fig" rid="glia23730-fig-0003">3</xref>d) and vimentin (immature astrocyte marker Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0008">S7</xref>a). More electroporated GFP+ cells in the striatum expressed GFAP or S100β after Gal‐3 OE (Figure <xref ref-type="fig" rid="glia23730-fig-0003">3</xref>f), and fewer expressed vimentin (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0008">S7</xref>b). These data suggest that in the striatum, Gal‐3 OE increases astrocytic differentiation of SVZ‐derived glia. In contrast to GFAP and S100β, significantly fewer labeled cells expressed the oligodendrocyte marker Olig2 after Gal‐3 OE (Figure <xref ref-type="fig" rid="glia23730-fig-0003">3</xref>e,g). These data indicate that Gal‐3 OE in the plSVZ caused a shift in SVZ glial progenitor fate choices by augmenting astrogenesis and reducing oligodendrogenesis.</p>
</sec>
<sec id="glia23730-sec-0015">
<label>3.3</label>
<title>Galectin‐3 overexpression increases BMP signaling</title>
<p>Since BMP signaling in the SVZ reduces oligodendrogenesis, and promotes astrocyte differentiation (Gomes et al., <xref ref-type="ref" rid="glia23730-bib-0018">2003</xref>) we examined the potential role of this signaling pathway in Gal‐3 function. We first confirmed that Gal‐3 binds to BMPR1α as has been suggested (Zhang et al., <xref ref-type="ref" rid="glia23730-bib-0063">2017</xref>) and then tested the hypothesis that BMPR1α is necessary for Gal‐3's effects. We expressed Gal‐3, Flag‐tagged BMPR1α, and HA‐tagged BMPR2 in HEK293T cells and determined if Gal‐3 and BMPR1α and/or BMPR2 co‐immunoprecipitate. Gal‐3 was complexed with BMPR1α but not BMPR2 (Figure <xref ref-type="fig" rid="glia23730-fig-0004">4</xref>a). The role of Gal‐3 on BMP signaling was unknown, thus, we assessed the in vivo SVZ expression of phosphorylated‐Smad/1/5/8 (pSmad1/5/8), which is increased upon canonical BMP signaling. We confirmed that a subset of pSmad1/5/8+ cells in controls co‐expressed Gal‐3 (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0008">S7</xref>c). This suggested baseline Gal‐3 may regulate BMP signaling, yet Gal‐3 knockdown did not affect pSmad1/5/8 levels in the SVZ (Figure <xref ref-type="fig" rid="glia23730-fig-0004">4</xref>b,c). Conversely, Gal‐3 OE increased pSmad1/5/8 immunofluorescence and more than doubled the percentage of pSmad1/5/8+ electroporated cells in the SVZ 3DPE (Figure <xref ref-type="fig" rid="glia23730-fig-0004">4</xref>b,c).</p>
<fig fig-type="Figure" id="glia23730-fig-0004" orientation="portrait" position="float" xml:lang="en">
<label>Figure 4</label>
<caption>
<p>Gal‐3 increases BMP signaling. (a) Co‐immunoprecipitation of Gal‐3 and BMPR1α and BMPR2. (b) Representative confocal images 3DPE. DAPI+ nuclei, mCherry+ electroporated cells, and pSmad 1/5/8+ cells. Arrows indicate pSmad1/5/8+ and arrowheads pSmad1/5/8‐labeled cells. Boxed areas are enlarged as orthogonal views. Scale bars: 20 μm for main panels, 5 μm for insets. (c) Quantification of B. One‐way ANOVA, Tukey's test for multiple comparisons. <italic>n</italic> = 5–6. (d) Western blot 24 hr after nucleofection with shNT (control), shGal‐3, or Gal‐3 OE, cells were treated with control or 5 ng/ml BMP4 for 24 hr. Immunoblot for pSmad 1/5/8, total Smad1 and β‐Actin. (e) Quantification of pSmad1/5/8 band intensities from (A1‐2) normalized to total Smad 1. 2‐way ANOVA</p>
</caption>
<graphic id="nlm-graphic-9" xlink:href="GLIA-68-435-g004"></graphic>
</fig>
<p>We next studied the effects of Gal‐3 and BMP4 on pSmad1/5/8 levels compared to total Smad5 or Smad1 using western blots. Gal‐3 regulated BMP signaling by increasing the phosphorylation of pSmad1/5/8 without altering total Smad protein content (Figures <xref ref-type="fig" rid="glia23730-fig-0004">4</xref>d,e and S7d,e). To confirm that Gal‐3 increases BMP signaling, a BMP signaling reporter (BRE‐Luciferase) was used to measure BMP signaling in plSVZ‐derived neurospheres after Gal‐3 OE or KD. Consistent with the in vivo data, BMP signaling was significantly increased 2 days after Gal‐3 OE compared to control, whereas knockdown caused slight but non‐significant reductions in BMP signaling (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0008">S7</xref>f). These data show a novel function for increased Gal‐3, it binds to BMPR1α and positively regulates BMP signaling in the plSVZ.</p>
<p>To determine if the converse is true and if BMP signaling regulates Gal‐3 expression we used qPCR after BMP4 stimulation of neurospheres in vitro. As expected (Ying, Nichols, Chambers, &amp; Smith, <xref ref-type="ref" rid="glia23730-bib-0060">2003</xref>), Id1 levels were increased after BMP4 treatment, providing a positive control (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0008">S7</xref>g). In contrast, Gal‐3 mRNA levels were reduced 24 and 48 hr after BMP4 treatment of SVZ cells (Figure <xref ref-type="supplementary-material" rid="glia23730-supitem-0008">S7</xref>g), suggesting negative feedback on Gal‐3 transcription. Thus, our data indicate that while Gal‐3 induced BMP signaling, BMP signaling in turn suppressed Gal‐3 expression.</p>
</sec>
<sec id="glia23730-sec-0016">
<label>3.4</label>
<title>BMPR1α signaling is necessary for galectin‐3 to increase astrogenesis</title>
<p>We found that Gal‐3 positively regulates BMP signaling, thus we next investigated if Gal‐3's effect on SVZ gliogenic fate choice is dependent on BMP signaling. Control, Gal‐3 OE, Cre or Gal‐3 OE + Cre plasmids were electroporated into the plSVZ of P2 BMPR1α<sup>fl/fl</sup> mice and brains harvested at 17DPE (Figure <xref ref-type="fig" rid="glia23730-fig-0005">5</xref>a). We used antibodies against S100β and GFAP to label astrocytes, and Olig2 to label oligodendrocytes (Figure <xref ref-type="fig" rid="glia23730-fig-0005">5</xref>b,d). Cre plasmids electroporated with Gal‐3 OE abolished the increase in the proportion of S100β + newborn glial cells observed in Gal‐3 OE alone (Figure <xref ref-type="fig" rid="glia23730-fig-0005">5</xref>c), suggesting that BMPR1α signaling was necessary for the Gal‐3 OE effects on glial fate choice. Compared to Gal‐3 OE alone, co‐electroporating Cre plasmids with Gal‐3 OE showed a non‐significant reduction in the proportion of GFP+ striatal cells that expressed GFAP (<italic>p</italic> = .07) (Figure <xref ref-type="fig" rid="glia23730-fig-0005">5</xref>e). However, the proportion of GFP+ striatal cells that expressed Olig2 after Gal‐3 OE was normalized (<italic>p</italic> &lt; .05) from very low to control levels upon conditional loss of the BMPR1α (Figure <xref ref-type="fig" rid="glia23730-fig-0005">5</xref>e). These data indicate that loss of the BMPR1α restored oligodendrogenesis and partially rescued the increased astrogenesis after Gal‐3 OE.</p>
<fig fig-type="Figure" id="glia23730-fig-0005" orientation="portrait" position="float" xml:lang="en">
<label>Figure 5</label>
<caption>
<p>BMPR1α is necessary for Gal‐3's effects. (a) Plasmids, mouse, and electroporation. (b) Confocal images, arrows indicate S100β + and arrowheads S100β negative cells. Scale bars: 20 μm in panels,10 μm in insets. (c) Quantification of B showing GFP control‐normalized proportions of S100β + striatal cells. (d) Confocal and projection images, arrows indicate GFAP+, arrowheads Olig2+, and double arrowheads GFAP+Olig2+ cells. (e) Quantification of D. Mann–Whitney U test. <italic>n</italic> = 3–5. Mean ± <italic>SEM</italic>. <italic>p</italic> value: * &lt; .05. (f) Maximal projection images showing morphological assessment of striatal cells 17DPE in controls, Gal‐3 OE, or Gal‐3 OE + Cre in BMPR1α<sup>fl/fl</sup> mice. Arrows indicate astrocyte‐like cells (upper panel in the control group), and arrowheads oligodendrocyte‐like cells (lower panel in the control group). Scale bars: 20 μm. (g) The GFP control‐normalized proportion of striatal cells that were morphologically oligodendrocyte‐like increased whereas those that were astrocyte‐like decreased in the Gal‐3 OE + Cre in BMPR1α<sup>fl/fl</sup> mice compared to Gal‐3 OE. Mann–Whitney U test. <italic>n</italic> = 3–5. (h) Co‐expression patterns of GFAP and Olig2 in electroporated groups. The percent of labeled GFP+ cells that were either Olig2+ or GFAP+ was not significantly different between the Cre and Gal‐3 OE + Cre groups. Gal‐3, Galectin‐3; SVZ, subventricular zone</p>
</caption>
<graphic id="nlm-graphic-11" xlink:href="GLIA-68-435-g005"></graphic>
</fig>
<p>To further confirm that BMPR1α was required for inducing astrogenesis after Gal‐3 OE we examined cell morphology (Figure <xref ref-type="fig" rid="glia23730-fig-0005">5</xref>f). Confirming our data above, Gal‐3 OE alone increased the percentage of cells with astrocytic morphology compared to controls but decreased the percentage of cells with oligodendrocytic morphology (Figure <xref ref-type="fig" rid="glia23730-fig-0005">5</xref>g). In contrast, co‐electroporation of Gal‐3 OE with Cre to remove BMPR1α reversed this effect and significantly increased oligodendrocyte‐like cells (<italic>p</italic> &lt; .01) and decreased astrocyte‐like cells (<italic>p</italic> &lt; .05) (Figure <xref ref-type="fig" rid="glia23730-fig-0005">5</xref>g). Electroporation of Cre plasmids only were indistinguishable from Cre + Gal‐3 OE, providing further evidence that signaling through BMPR1α is downstream to Gal‐3's action. Interestingly, we found that co‐electroporating Cre + Gal‐3 OE significantly increased the population of double‐positive GFAP+Olig2+ cells in the striatum (2.08 ± 2.95% control, 3.14 ± 2.78% Gal‐3 OE; 14.47 ± 2.69% Gal‐3 OE + Cre; <italic>p</italic> &lt; .01 one‐way ANOVA, Figure <xref ref-type="fig" rid="glia23730-fig-0005">5</xref>h). This suggests that loss of BMP signaling de‐repressed Olig2+ expression in GFAP+ striatal glia. Taken together, we provide strong evidence that Gal‐3's effect on gliogenic fate choice is dependent on BMP signaling.</p>
</sec>
<sec id="glia23730-sec-0017">
<label>3.5</label>
<title>Galectin‐3 expression increases in the forebrain of patients with perinatal hypoxia ischemia</title>
<p>Gal‐3 is increased in human brains with a variety of pathologies such as multiple sclerosis (James et al., <xref ref-type="ref" rid="glia23730-bib-0024">2016</xref>). We predicted that Gal‐3 would be increased in the striatum and the adjacent SVZ since the lining of the lateral ventricle is susceptible to perinatal damage as in periventricular leukomalacia. We selected <italic>n</italic> = 14 cases with perinatal H/I damage and focused on the lateral ventricle and adjacent striatum. Gal‐3 immunohistochemistry revealed Gal‐3+ cells in the SVZ and CN of most patients with minimal, acute, subacute, and chronic H/I (Figure <xref ref-type="fig" rid="glia23730-fig-0006">6</xref>a,b,d,e). Gal‐3+ cells in the striatum and the SVZ were usually found in distinct subregions or clusters and exhibited a variety of morphologies. Gal‐3+ cells were also found in the cerebral cortex of most H/I cases (data not shown). A few cases had negligible Gal‐3 immunoreactivity in the regions examined (Figure <xref ref-type="fig" rid="glia23730-fig-0006">6</xref>c) and these provided useful negative controls. Based on neuropathological examination, absence of inflammation was characteristic of cases with minimal or acute H/I, thus these cases were grouped together. Subacute and chronic cases were also similar in the presence of inflammatory response/vascular changes and these were grouped together for quantification. We selected areas in the striatum and SVZ with Gal‐3+ cells and quantified the percent of cells within them that exhibited robust Gal‐3+ immunoreactivity (see Supplementary materials and methods). The results show significant differences between the two groups (minimal/acute H/I vs. subacute/chronic H/I); the subacute/chronic group exhibited significantly more strongly labeled Gal‐3+ cells (6.22 ± 2.30%) compared with the minimal/acute group (0.69 ± 0.02%) (<italic>p</italic> = .04).</p>
<fig fig-type="Figure" id="glia23730-fig-0006" orientation="portrait" position="float" xml:lang="en">
<label>Figure 6</label>
<caption>
<p>Gal‐3 expression is increased in human perinatal hypoxia/ischaemia. (a) High magnification photomicrograph of Gal‐3 immunopositive cells in the striatum of a patient with subacute H/I. Arrows point to two Gal‐3+ cells. (b) Gal‐3 + cells in the SVZ of a patient with acute hypoxia. Typical examples shown with arrows. There is a high density of small glia‐like nuclei in the SVZ and in this section the SVZ is widely expanded. The inset show a low magnification image of the section and the small red outline within it shows the location of b. LV, lateral ventricle. STR, striatum. (c) An example of a section from an individual with minimal hypoxia/ischemia containing no detectable Gal‐3 immunoreactivity. The section includes the ependymal layer (E) of the LV, the SVZ and the striatum. The inset shows the location of the photomicrograph section in (c). (d) High magnification photomicrograph of several Gal‐3+ cells in the striatum of a subacute H/I patient. (e) A chronic H/I patient with strong Gal‐3 immunopositive cells in the ependymal layer (arrow) and in the adjacent SVZ and CN. In this section, the border of the SVZ and CN was distinct and is demarcated with a thin black line. Scale bars are indicated in the panels. Gal‐3, Galectin‐3; SVZ, subventricular zone</p>
</caption>
<graphic id="nlm-graphic-13" xlink:href="GLIA-68-435-g006"></graphic>
</fig>
</sec>
</sec>
<sec id="glia23730-sec-0018">
<label>4</label>
<title>DISCUSSION</title>
<p>The SVZ is a major source of glial cells in the postnatal forebrain, yet the factors that regulate gliogenesis and that balance astrocyte versus oligodendrocyte production are unclear. Our work disentangled Gal‐3 from inflammation‐related effects and revealed that Gal‐3 loss‐of‐function reduces postnatal gliogenesis while increasing Gal‐3 promotes it. Gal‐3 OE was also sufficient to cause a fate shift, it increased astrogenesis and decreased oligodendrogenesis. We found that Gal‐3 binds to the BMPR1α, that it increases BMP signaling, and that the BMPR1α is necessary for the fate shift caused by Gal‐3 OE. We also showed here that Gal‐3 expression is increased in the human perinatal SVZ and striatum in hypoxia/ischemia, further justifying the study of Gal‐3 OE. Together, our data reveal a novel mechanism showing Gal‐3 regulates basal gliogenesis and together with BMP signaling may shape postnatal SVZ glial fate choices.</p>
<p>One of our central questions had been whether Gal‐3 regulates normal development or if it only becomes functionally relevant when it is increased in disease. Gal‐3 knockout mice show few phenotypic changes, suggesting Gal‐3 is dispensable for healthy development and function (Colnot et al., <xref ref-type="ref" rid="glia23730-bib-0010">1998</xref>). However, Gal‐3 is ubiquitously increased in brain pathology and regulates various functions including tumorigenesis (Liu &amp; Rabinovich, <xref ref-type="ref" rid="glia23730-bib-0032">2005</xref>). Models of stroke and multiple sclerosis in adult Gal‐3 knockout mice demonstrate it is necessary for angiogenesis and chemokine‐induced immune cell infiltration, respectively (Hillis et al., <xref ref-type="ref" rid="glia23730-bib-0021">2016</xref>; James et al., <xref ref-type="ref" rid="glia23730-bib-0024">2016</xref>; C. C. Young et al., <xref ref-type="ref" rid="glia23730-bib-0061">2014</xref>). Inflammation plays pivotal roles in these diseases, causing multiple cellular and molecular changes that make it difficult to interpret Gal‐3's effects. Additionally, Gal‐3 can itself induce inflammation by attracting and activating macrophages during ischemia, demyelination, and obesity (Hoyos et al., <xref ref-type="ref" rid="glia23730-bib-0023">2014</xref>; Lalancette‐Hebert et al., <xref ref-type="ref" rid="glia23730-bib-0026">2012</xref>; P. Li et al., <xref ref-type="ref" rid="glia23730-bib-0029">2016</xref>). Given this background, it was not altogether surprising that Gal‐3 expression was increased in the human brain in hypoxia/ischemia. H/I events and resultant pathologies are quite variable in humans and are thus difficult to study in postmortem sections and in animal models. We found a range of severity in Gal‐3 expression that was lesser in minimal and acute cases but greater overall in subacute and chronic cases.</p>
<p>By not using a disease model, we provide strong evidence that Gal‐3 OE itself does not cause inflammation in the absence of injury in the postnatal brain. We examined the SVZ and striatum at 3, 7, and 17 days after Gal‐3 OE and showed that CD45+ and Iba1+ cells were unaffected. The former labels all immune cells and the latter is used as a marker of microglia. Neither cell density nor activation state was altered after Gal‐3 OE. We also showed that Gal‐3 OE and knockdown did not increase the rate of apoptosis, which was an important control as cell death can occur during inflammation. Although the expression of various inflammatory cytokines may have been altered by Gal‐3 in this study, based on the data in aggregate, we believe inflammation was not induced. Thus, we studied Gal‐3 function in the absence of inflammation allowing us to uniquely assess its specific effects when increased in expression.</p>
<p>The postnatal SVZ is gliogenic (Levison et al., <xref ref-type="ref" rid="glia23730-bib-0027">1993</xref>; Levison &amp; Goldman, <xref ref-type="ref" rid="glia23730-bib-0028">1993</xref>), astrogenesis predominates in the first week and is gradually overtaken by oligodendrogenesis (Sauvageot &amp; Stiles, <xref ref-type="ref" rid="glia23730-bib-0052">2002</xref>). Our data reveal postnatal Gal‐3 as being instrumental in overall plSVZ gliogenesis; plSVZ‐derived striatal gliogenesis was reduced after Gal‐3 down‐regulation and conditional knockout and increased after Gal‐3 overexpression. These data show that Gal‐3 is instrumental in regulating rates of SVZ‐derived gliogenesis in the striatum. Our study was well within the second half of the gliogenic period, we electroporated at P2 and evaluated at P4 and later time points. In rodents, the onset of astrogenesis is E18 with peak astrocyte progenitor proliferation during the early postnatal period (Miller &amp; Gauthier, <xref ref-type="ref" rid="glia23730-bib-0039">2007</xref>). Therefore, electroporating Gal‐3 constructs at E18 may provide additional insight into Gal‐3's effects on gliogenesis, and when Gal‐3 signaling is most important in gliogenesis.</p>
<p>Gal‐3 gain‐of‐function did not just generically increase gliogenesis but specifically increased astrogenesis by 17DPE. Gal‐3 OE also increased the labeling index of SVZ GFAP+ cells that expressed Ki67 at 7DPE. We do not know the exact identity of these GFAP+Ki67+ cells, as they could be mitotic NSCs or glial progenitors. However, Gal‐3 OE did not increase the percent of GFAP+BrdU+ cells (label‐retaining cells) or GFAP+BrdU+EdU+ (mitotically active label‐retaining cells) suggesting Gal‐3 OE did not alter BrdU label‐retaining NSCs or their cell‐cycle re‐entry. SVZ GFAP+ cells that exhibited increased Ki67 expression upon Gal‐3 OE may have been astroglial precursors or even niche astrocytes, but the latter are not typically mitotic (Doetsch, Caille, Lim, Garcia‐Verdugo, &amp; Alvarez‐Buylla, <xref ref-type="ref" rid="glia23730-bib-0012">1999</xref>). Interestingly, we also showed that Gal‐3 OE increased the percent of SVZ GFAP+ cells that express Phi3. This suggests that rather than the increase in Ki67 labeling index possibly being due to lengthened cell cycle time, it is due to increased numbers of proliferating SVZ glial precursor cells. Moreover, SVZ‐derived striatal astrocytes exhibited a more mature phenotype after Gal‐3 OE, displaying reduced expression of the immature astrocyte marker vimentin and increased expression of the mature markers S100β and GFAP. This is compatible with a scenario where Gal‐3 OE increases astrocyte maturation. At P19 the predominant glial cell type generated are oligodendrocytes, but Gal‐3 OE reversed this and reduced oligodendrogenesis, suggesting it also affects glial fate choices.</p>
<p>An alternative explanation for the altered astrocyte to oligodendrocyte ratio after overexpression is that Gal‐3 induced cell death. Increased cell death of oligodendrocytes and/or decreased cell death of astrocytes could have contributed to the increased ratio of astrocytes to oligodendrocytes. However, we showed that Gal‐3 OE did not significantly alter the number of cells going through apoptosis (A.Caspase‐3+) at 7 or 17 DPE. As well, it is difficult to characterize which cell type is undergoing apoptosis as marker proteins generally degrade while cells are dying. We did not find any evidence of A.Caspase‐3+ and Olig2 colocalization in the SVZ at 3 DPE (data not shown). Other types of cell death such as ferroptosis or necroptosis may also have affected our cell numbers, but these are rare events in homeostasis and normal development and we would expect baseline levels of these types of cell death to be very low. Investigating other modalities of cell death in the pSVZ is largely unexplored and was beyond the scope of this study.</p>
<p>The subregional differences of the SVZ niche are fascinating and important in terms of embryonic origins and cell subtype generation (K. M. Young, Fogarty, Kessaris, &amp; Richardson, <xref ref-type="ref" rid="glia23730-bib-0062">2007</xref>). There is excellent evidence from the Raineteau group that Wnt signaling, which can influence gliogenesis, is restricted to the dorsal SVZ (Azim, Fischer, et al., <xref ref-type="ref" rid="glia23730-bib-0004">2014</xref>; Azim, Rivera, Raineteau, &amp; Butt, <xref ref-type="ref" rid="glia23730-bib-0005">2014</xref>). As well, the Doetsch group have recently shown with single cell RNAseq that the septal SVZ may be primarily gliogenic (Mizrak et al., <xref ref-type="ref" rid="glia23730-bib-0042">2019</xref>). Therefore, in future work it will be important to determine if Gal‐3 regulates gliogenesis in other SVZ subregions.</p>
<p>BMP exposure increases astrogenesis and astrocytic fate/differentiation (Gross et al., <xref ref-type="ref" rid="glia23730-bib-0019">1996</xref>; Mabie et al., <xref ref-type="ref" rid="glia23730-bib-0035">1997</xref>). Therefore, the glial fate‐shift induced by Gal‐3 OE suggested that BMP signaling was involved. Multiple experimental approaches demonstrated that indeed this was the case. We showed that Gal‐3 increased BMP signaling and it is important to note that Gal‐3's effects on BMP signaling preceded the striatal fate shift, suggesting causation. Importantly, reducing BMP signaling via BMPR1α conditional knockout blocked the Gal‐3 OE‐induced shift from oligodendrogenesis to astrogenesis. This shows Gal‐3's effects are largely dependent on BMPR1α signaling. However, the Gal‐3 OE‐induced GFAP upregulation was only partially reversed after BMPR1α loss, suggesting it may regulate GFAP expression in a BMP‐independent pathway.</p>
<p>Postnatal electroporation results in labeling of cells in the expected temporal lineage progression in the SVZ (Doetsch et al., <xref ref-type="ref" rid="glia23730-bib-0012">1999</xref>; Garcia, Doan, Imura, Bush, &amp; Sofroniew, <xref ref-type="ref" rid="glia23730-bib-0016">2004</xref>). Electroporation initially targets the radial glia‐like stem cells lining the lateral ventricles (Barnabe‐Heider et al., <xref ref-type="ref" rid="glia23730-bib-0006">2008</xref>; Boutin et al., <xref ref-type="ref" rid="glia23730-bib-0007">2008</xref>; Chesler et al., <xref ref-type="ref" rid="glia23730-bib-0008">2008</xref>; Sun et al., <xref ref-type="ref" rid="glia23730-bib-0057">2018</xref>). Within a few days, as the stem cells divide, labeled transit‐amplifying progenitor daughter cells appear. By approximately a week post electroporation, lineage‐specific progenitors—neuroblasts or glioblasts are labeled in the SVZ. Thereafter, labeled neuroblasts and glioblasts can be observed migrating to their target destinations in the OB, striatum and forebrain (Barnabe‐Heider et al., <xref ref-type="ref" rid="glia23730-bib-0006">2008</xref>; Boutin et al., <xref ref-type="ref" rid="glia23730-bib-0007">2008</xref>; Chesler et al., <xref ref-type="ref" rid="glia23730-bib-0008">2008</xref>; Sun et al., <xref ref-type="ref" rid="glia23730-bib-0057">2018</xref>). Based on our analysis of Gal‐3 knockdown and conditional knockout, loss of Gal‐3 occurred within 3 days and lasted at least 17DPE. Similarly, Gal‐3 OE occurred at all these time points. We do not know precisely at what stage of lineage progression Gal‐3 regulates gliogenesis. However, we know that BMP signaling is upregulated following Gal‐3 overexpression as early as 2 days (BRE‐luciferase in vitro) and 3 days (pSMAD in vivo). This is followed by an increase in the Ki67 as well as Phi3 labeling indices of SVZ GFAP+ cells at 7DPE, culminating in the gliogenic effect observed at 17DPE. Future work using cell stage specific Cre driver lines may help elucidate when during SVZ lineage progression Gal‐3 mediated BMP signaling regulates gliogenesis.</p>
<p>BMP signaling mediates NSC quiescence and suppresses proliferation (Mercier &amp; Douet, <xref ref-type="ref" rid="glia23730-bib-0038">2014</xref>; Mira et al., <xref ref-type="ref" rid="glia23730-bib-0040">2010</xref>). We thus expected Gal‐3 to affect NSC self‐renewal. However, Gal‐3 OE did not alter pSVZ NSC proportions, self‐renewal, activation, or olfactory bulb neurogenesis. Gal‐3 mediates Notch signaling in osteoblasts (Nakajima et al., <xref ref-type="ref" rid="glia23730-bib-0046">2014</xref>) and may have stimulated Notch signaling to increase NSC maintenance and counterbalance its effects on BMP signaling. Alternatively, one can envisage a scenario where the SVZ harbors Gal‐3 responsive and Gal‐3 nonresponsive cell populations. Gal‐3 may have caused terminal differentiation of Gal‐3‐responsive cells and thereby affected a subpopulation of pSVZ cells, while the remaining Gal‐3 nonresponsive cells compensated for any shrinkage of the NSC pool. Supporting this, Gal‐3 affected BMP signaling in a subset of SVZ cells. Since neither NSC dynamics nor OB neurogenesis were influenced by Gal‐3 OE, we propose Gal‐3 responsive cells are glial progenitors. Indeed, Gal‐3 OE changes were restricted to the glial lineage.</p>
<p>We propose that the mechanism whereby Gal‐3 increases BMP signaling and regulates gliogenic fate choices involves direct interaction between Gal‐3 and BMPR1α. There was evidence that BMPR1α and BMPR2 are glycosylated and bind Gal‐3 in other systems (Hirschhorn, Levi‐Hofman, Danziger, Smorodinsky, &amp; Ehrlich, <xref ref-type="ref" rid="glia23730-bib-0022">2017</xref>; Zhang et al., <xref ref-type="ref" rid="glia23730-bib-0063">2017</xref>). Interestingly, loss of BMPR1α glycosylation reduced its expression on the cell membrane and decreased Smad1/5/8 phosphorylation (Hirschhorn et al., <xref ref-type="ref" rid="glia23730-bib-0022">2017</xref>). We found that BMPR1α is necessary for the Gal‐3 OE effects and confirmed that Gal‐3 binds to this receptor. The downstream effect of increased pSmad1/5/8 is a hallmark of BMP signaling. Gal‐3 can bind to a variety of glycosylated receptors such as the EGFR and transforming growth factor beta (TGFBR) receptors, delaying their endocytosis and prolonging their activation (Partridge et al., <xref ref-type="ref" rid="glia23730-bib-0048">2004</xref>; Zhang et al., <xref ref-type="ref" rid="glia23730-bib-0063">2017</xref>). We postulate that a similar mechanism may prolong and enhance BMPR1α signaling, but further studies are needed to validate that idea. Alternative mechanisms include signaling via tyrosine kinase receptors like EGFR and activation of the MAPK/ERK pathways. Gal‐3 does not bind to EGFR in adult SVZ cells but loss of Gal‐3 function increased the relative levels of pEGFR (Comte et al., <xref ref-type="ref" rid="glia23730-bib-0011">2011</xref>). Therefore, it is also possible that Gal‐3 affects alternative signaling pathways in plSVZ cells such as EGFR‐driven MAPK/ERK. Future biochemical studies will be necessary to determine if these pathways are activated by Gal‐3 in the SVZ.</p>
<p>We showed in this study that Gal‐3 is necessary and sufficient for plSVZ gliogenesis, is increased in human H/I, but has inflammation‐independent functions in the healthy murine brain. Without eliciting inflammation, augmenting Gal‐3 levels increased gliogenesis whereas decreasing it reduced gliogenesis. Furthermore, increasing Gal‐3 expression induced astrocytic fate and differentiation, and simultaneously suppressed oligodendrogenesis; an effect dependent on BMP signaling. We also demonstrated that Gal‐3 interacts with BMPR1α and increases BMP signaling in the plSVZ. The developmental effects and molecular mechanisms uncovered contribute to our understanding of normal gliogenesis and have important implications for disease.</p>
</sec>
<sec id="glia23730-sec-0020">
<title>AUTHOR CONTRIBUTIONS</title>
<p>F.G.S and O.A conceptualized the study; O.A., L.C.S., J.N., S.D., M.M., I.A., T.T., and V.M.L. performed experiments; O.A., E.O., and F.G.S. drafted and wrote the article. All authors approved the final version of this manuscript.</p>
</sec>
<sec id="glia23730-sec-0021" sec-type="COI-statement">
<title>CONFLICT OF INTERESTS</title>
<p>All authors have no conflict of interests to disclose.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="glia23730-supitem-0001">
<caption>
<p>
<bold>Appendix S1:</bold> Supporting Information</p>
</caption>
<media xlink:href="GLIA-68-435-s001.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="glia23730-supitem-0002">
<caption>
<p>
<bold>Supplementary Figure S1</bold>
</p>
</caption>
<media xlink:href="GLIA-68-435-s002.tiff">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="glia23730-supitem-0003">
<caption>
<p>
<bold>Supplementary Figure S2</bold>
</p>
</caption>
<media xlink:href="GLIA-68-435-s003.tiff">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="glia23730-supitem-0004">
<caption>
<p>
<bold>Supplementary Figure S3</bold>
</p>
</caption>
<media xlink:href="GLIA-68-435-s004.tiff">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="glia23730-supitem-0005">
<caption>
<p>
<bold>Supplementary Figure S4</bold>
</p>
</caption>
<media xlink:href="GLIA-68-435-s005.tiff">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="glia23730-supitem-0006">
<caption>
<p>
<bold>Supplementary Figure S5</bold>
</p>
</caption>
<media xlink:href="GLIA-68-435-s006.tiff">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="glia23730-supitem-0007">
<caption>
<p>
<bold>Supplementary Figure S6</bold>
</p>
</caption>
<media xlink:href="GLIA-68-435-s007.tiff">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="glia23730-supitem-0008">
<caption>
<p>
<bold>Supplementary Figure S7</bold>
</p>
</caption>
<media xlink:href="GLIA-68-435-s008.tiff">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack id="glia23730-sec-0019">
<title>ACKNOWLEDGMENTS</title>
<p>We thank the following for plasmids; A. Chenn for pTOP‐dGFP‐CAG‐mCherry, C. Cepko for pCAG‐Cre‐IRES2‐GFP, M. Roussel and P. ten Dijkep for GL3 BRE‐Luciferase, I. Tomlinson for pGL4.75 (hRluc/CMV), J. Begbie for pSilencer 2.0‐U6 and S. Srinivas for pCS‐TdTomato‐m2A. We thank T. Rodriguez for the BMPR1α<sup>fl/fl</sup> mice. R. Wade‐Martins, S. Srinivas, Z. Molnar helped with reagents and equipment. We thank M. Esiri and J. Goldman for their help in the neuropathological assessment of the human brain sections. We thank O. Ansorge for his help with the Oxford Brain Bank. We thank J. Kessler, C. Bardella, I. Tomlinson, S. Parinello, M. Mommersteeg, D. Sparrow and Szele lab members for helpful comments on the manuscript. I. A. funded by Institutional Excellence in Higher Education Grant (FIKP, Semmelweis University) and Departmental Start‐up Grant (Semmelweis University).</p>
</ack>
<sec id="glia23730-sec-0023" sec-type="data-availability">
<title>DATA AVAILABILITY STATEMENT</title>
<p>The data that support the findings of this study are available from the corresponding author FS upon reasonable request.</p>
</sec>
<ref-list content-type="cited-references" id="glia23730-bibl-0001">
<title>REFERENCES</title>
<ref id="glia23730-bib-0001">
<mixed-citation id="glia23730-cit-0001" publication-type="journal">
<string-name>
<surname>Adorjan</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Ahmed</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Feher</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Torso</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Krug</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Esiri</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Szele</surname>, <given-names>F. G.</given-names>
</string-name> (<year>2017</year>). <article-title>Calretinin interneuron density in the caudate nucleus is lower in autism spectrum disorder</article-title>. <source xml:lang="en"/>Brain, <volume>140</volume>, <fpage>2028</fpage>–<lpage>2040</lpage>.<pub-id pub-id-type="pmid">29177493</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0002">
<mixed-citation id="glia23730-cit-0002" publication-type="journal">
<string-name>
<surname>Adorjan</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Tyler</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Bhaduri</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Demharter</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Finszter</surname>, <given-names>C. K.</given-names>
</string-name>, <string-name>
<surname>Bako</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Molnar</surname>, <given-names>Z.</given-names>
</string-name> (<year>2019</year>). <article-title>Neuroserpin expression during human brain development and in adult brain revealed by immunohistochemistry and single cell RNA sequencing</article-title>. <source xml:lang="en"/>Journal of Anatomy, <volume>235</volume>(<issue>3</issue>), <fpage>543</fpage>–<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1111/joa.12931</pub-id>
<pub-id pub-id-type="pmid">30644551</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0003">
<mixed-citation id="glia23730-cit-0003" publication-type="journal">
<string-name>
<surname>Alfonso‐Loeches</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Pascual‐Lucas</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Blanco</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Sanchez‐Vera</surname>, <given-names>I.</given-names>
</string-name>, &amp; <string-name>
<surname>Guerri</surname>, <given-names>C.</given-names>
</string-name> (<year>2010</year>). <article-title>Pivotal role of TLR4 receptors in alcohol‐induced neuroinflammation and brain damage</article-title>. <source xml:lang="en"/>The Journal of Neuroscience, <volume>30</volume>(<issue>24</issue>), <fpage>8285</fpage>–<lpage>8295</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0976-10.2010</pub-id>
<pub-id pub-id-type="pmid">20554880</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0004">
<mixed-citation id="glia23730-cit-0004" publication-type="journal">
<string-name>
<surname>Azim</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Hurtado‐Chong</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Draganova</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Cantu</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Zemke</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Raineteau</surname>, <given-names>O.</given-names>
</string-name> (<year>2014</year>). <article-title>Persistent Wnt/beta‐catenin signaling determines dorsalization of the postnatal subventricular zone and neural stem cell specification into oligodendrocytes and glutamatergic neurons</article-title>. <source xml:lang="en"/>Stem Cells, <volume>32</volume>(<issue>5</issue>), <fpage>1301</fpage>–<lpage>1312</lpage>. <pub-id pub-id-type="doi">10.1002/stem.1639</pub-id>
<pub-id pub-id-type="pmid">24449255</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0005">
<mixed-citation id="glia23730-cit-0005" publication-type="journal">
<string-name>
<surname>Azim</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Rivera</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Raineteau</surname>, <given-names>O.</given-names>
</string-name>, &amp; <string-name>
<surname>Butt</surname>, <given-names>A. M.</given-names>
</string-name> (<year>2014</year>). <article-title>GSK3beta regulates oligodendrogenesis in the dorsal microdomain of the subventricular zone via Wnt‐beta‐catenin signaling</article-title>. <source xml:lang="en"/>Glia, <volume>62</volume>(<issue>5</issue>), <fpage>778</fpage>–<lpage>779</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22641</pub-id>
<pub-id pub-id-type="pmid">24677550</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0006">
<mixed-citation id="glia23730-cit-0006" publication-type="journal">
<string-name>
<surname>Barnabe‐Heider</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Meletis</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Eriksson</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Bergmann</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Sabelstrom</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Harvey</surname>, <given-names>M. A.</given-names>
</string-name>, … <string-name>
<surname>Frisen</surname>, <given-names>J.</given-names>
</string-name> (<year>2008</year>). <article-title>Genetic manipulation of adult mouse neurogenic niches by in vivo electroporation</article-title>. <source xml:lang="en"/>Nature Methods, <volume>5</volume>(<issue>2</issue>), <fpage>189</fpage>–<lpage>196</lpage>.<pub-id pub-id-type="pmid">18204459</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0007">
<mixed-citation id="glia23730-cit-0007" publication-type="journal">
<string-name>
<surname>Boutin</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Diestel</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Desoeuvre</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Tiveron</surname>, <given-names>M. C.</given-names>
</string-name>, &amp; <string-name>
<surname>Cremer</surname>, <given-names>H.</given-names>
</string-name> (<year>2008</year>). <article-title>Efficient in vivo electroporation of the postnatal rodent forebrain</article-title>. <source xml:lang="en"/>PLoS One, <volume>3</volume>(<issue>4</issue>), e<fpage>1883</fpage>.</mixed-citation>
</ref>
<ref id="glia23730-bib-0008">
<mixed-citation id="glia23730-cit-0008" publication-type="journal">
<string-name>
<surname>Chesler</surname>, <given-names>A. T.</given-names>
</string-name>, <string-name>
<surname>Le Pichon</surname>, <given-names>C. E.</given-names>
</string-name>, <string-name>
<surname>Brann</surname>, <given-names>J. H.</given-names>
</string-name>, <string-name>
<surname>Araneda</surname>, <given-names>R. C.</given-names>
</string-name>, <string-name>
<surname>Zou</surname>, <given-names>D. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Firestein</surname>, <given-names>S.</given-names>
</string-name> (<year>2008</year>). <article-title>Selective gene expression by postnatal electroporation during olfactory interneuron nurogenesis</article-title>. <source xml:lang="en"/>PLoS One, <volume>3</volume>(<issue>1</issue>), e<fpage>1517</fpage>.</mixed-citation>
</ref>
<ref id="glia23730-bib-0009">
<mixed-citation id="glia23730-cit-0009" publication-type="journal">
<string-name>
<surname>Colak</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Mori</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Brill</surname>, <given-names>M. S.</given-names>
</string-name>, <string-name>
<surname>Pfeifer</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Falk</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Deng</surname>, <given-names>C.</given-names>
</string-name>, … <string-name>
<surname>Gotz</surname>, <given-names>M.</given-names>
</string-name> (<year>2008</year>). <article-title>Adult neurogenesis requires Smad4‐mediated bone morphogenic protein signaling in stem cells</article-title>. <source xml:lang="en"/>The Journal of Neuroscience, <volume>28</volume>(<issue>2</issue>), <fpage>434</fpage>–<lpage>446</lpage>.<pub-id pub-id-type="pmid">18184786</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0010">
<mixed-citation id="glia23730-cit-0010" publication-type="journal">
<string-name>
<surname>Colnot</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Ripoche</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Milon</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Montagutelli</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Crocker</surname>, <given-names>P. R.</given-names>
</string-name>, &amp; <string-name>
<surname>Poirier</surname>, <given-names>F.</given-names>
</string-name> (<year>1998</year>). <article-title>Maintenance of granulocyte numbers during acute peritonitis is defective in galectin‐3‐null mutant mice</article-title>. <source xml:lang="en"/>Immunology, <volume>94</volume>(<issue>3</issue>), <fpage>290</fpage>–<lpage>296</lpage>.<pub-id pub-id-type="pmid">9767409</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0011">
<mixed-citation id="glia23730-cit-0011" publication-type="journal">
<string-name>
<surname>Comte</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Kim</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Young</surname>, <given-names>C. C.</given-names>
</string-name>, <string-name>
<surname>van der Harg</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Hockberger</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Bolam</surname>, <given-names>P. J.</given-names>
</string-name>, … <string-name>
<surname>Szele</surname>, <given-names>F. G.</given-names>
</string-name> (<year>2011</year>). <article-title>Galectin‐3 maintains cell motility from the subventricular zone to the olfactory bulb</article-title>. <source xml:lang="en"/>Journal of Cell Science, <volume>124</volume>(<issue>Pt 14</issue>), <fpage>2438</fpage>–<lpage>2447</lpage>.<pub-id pub-id-type="pmid">21693585</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0012">
<mixed-citation id="glia23730-cit-0012" publication-type="journal">
<string-name>
<surname>Doetsch</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Caille</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Lim</surname>, <given-names>D. A.</given-names>
</string-name>, <string-name>
<surname>Garcia‐Verdugo</surname>, <given-names>J. M.</given-names>
</string-name>, &amp; <string-name>
<surname>Alvarez‐Buylla</surname>, <given-names>A.</given-names>
</string-name> (<year>1999</year>). <article-title>Subventricular zone astrocytes are neural stem cells in the adult mammalian brain</article-title>. <source xml:lang="en"/>Cell, <volume>97</volume>(<issue>6</issue>), <fpage>703</fpage>–<lpage>716</lpage>.<pub-id pub-id-type="pmid">10380923</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0013">
<mixed-citation id="glia23730-cit-0013" publication-type="journal">
<string-name>
<surname>Dumic</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Dabelic</surname>, <given-names>S.</given-names>
</string-name>, &amp; <string-name>
<surname>Flogel</surname>, <given-names>M.</given-names>
</string-name> (<year>2006</year>). <article-title>Galectin‐3: An open‐ended story</article-title>. <source xml:lang="en"/>Biochimica et Biophysica Acta, <volume>1760</volume>(<issue>4</issue>), <fpage>616</fpage>–<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2005.12.020</pub-id>
<pub-id pub-id-type="pmid">16478649</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0014">
<mixed-citation id="glia23730-cit-0014" publication-type="journal">
<string-name>
<surname>Ekdahl</surname>, <given-names>C. T.</given-names>
</string-name>, <string-name>
<surname>Claasen</surname>, <given-names>J.‐H.</given-names>
</string-name>, <string-name>
<surname>Bonde</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Kokaia</surname>, <given-names>Z.</given-names>
</string-name>, &amp; <string-name>
<surname>Lindvall</surname>, <given-names>O.</given-names>
</string-name> (<year>2003</year>). <article-title>Inflammation is detrimental for neurogenesis in adult brain</article-title>. <source xml:lang="en"/>PNAS, <volume>100</volume>(<issue>23</issue>), <fpage>13632</fpage>–<lpage>13637</lpage>.<pub-id pub-id-type="pmid">14581618</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0015">
<mixed-citation id="glia23730-cit-0015" publication-type="journal">
<string-name>
<surname>Fiorelli</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Azim</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>, <given-names>B.</given-names>
</string-name>, &amp; <string-name>
<surname>Raineteau</surname>, <given-names>O.</given-names>
</string-name> (<year>2015</year>). <article-title>Adding a spatial dimension to postnatal ventricular‐subventricular zone neurogenesis</article-title>. <source xml:lang="en"/>Development, <volume>142</volume>(<issue>12</issue>), <fpage>2109</fpage>–<lpage>2120</lpage>. <pub-id pub-id-type="doi">10.1242/dev.119966</pub-id>
<pub-id pub-id-type="pmid">26081572</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0016">
<mixed-citation id="glia23730-cit-0016" publication-type="journal">
<string-name>
<surname>Garcia</surname>, <given-names>A. D.</given-names>
</string-name>, <string-name>
<surname>Doan</surname>, <given-names>N. B.</given-names>
</string-name>, <string-name>
<surname>Imura</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Bush</surname>, <given-names>T. G.</given-names>
</string-name>, &amp; <string-name>
<surname>Sofroniew</surname>, <given-names>M. V.</given-names>
</string-name> (<year>2004</year>). <article-title>GFAP‐expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain</article-title>. <source xml:lang="en"/>Nature Neuroscience, <volume>7</volume>(<issue>11</issue>), <fpage>1233</fpage>–<lpage>1241</lpage>.<pub-id pub-id-type="pmid">15494728</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0017">
<mixed-citation id="glia23730-cit-0017" publication-type="journal">
<string-name>
<surname>Goings</surname>, <given-names>G. E.</given-names>
</string-name>, <string-name>
<surname>Kozlowski</surname>, <given-names>D. A.</given-names>
</string-name>, &amp; <string-name>
<surname>Szele</surname>, <given-names>F. G.</given-names>
</string-name> (<year>2006</year>). <article-title>Differential activation of microglia in neurogenic versus non‐neurogenic regions of the forebrain</article-title>. <source xml:lang="en"/>Glia, <volume>54</volume>(<issue>4</issue>), <fpage>329</fpage>–<lpage>342</lpage>.<pub-id pub-id-type="pmid">16862532</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0018">
<mixed-citation id="glia23730-cit-0018" publication-type="journal">
<string-name>
<surname>Gomes</surname>, <given-names>W. A.</given-names>
</string-name>, <string-name>
<surname>Mehler</surname>, <given-names>M. F.</given-names>
</string-name>, &amp; <string-name>
<surname>Kessler</surname>, <given-names>J. A.</given-names>
</string-name> (<year>2003</year>). <article-title>Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment</article-title>. <source xml:lang="en"/>Developmental Biology, <volume>255</volume>(<issue>1</issue>), <fpage>164</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1016/s0012-1606(02)00037-4</pub-id>
<pub-id pub-id-type="pmid">12618141</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0019">
<mixed-citation id="glia23730-cit-0019" publication-type="journal">
<string-name>
<surname>Gross</surname>, <given-names>R. E.</given-names>
</string-name>, <string-name>
<surname>Mehler</surname>, <given-names>M. F.</given-names>
</string-name>, <string-name>
<surname>Mabie</surname>, <given-names>P. C.</given-names>
</string-name>, <string-name>
<surname>Zang</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Santschi</surname>, <given-names>L.</given-names>
</string-name>, &amp; <string-name>
<surname>Kessler</surname>, <given-names>J. A.</given-names>
</string-name> (<year>1996</year>). <article-title>Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells</article-title>. <source xml:lang="en"/>Neuron, <volume>17</volume>(<issue>4</issue>), <fpage>595</fpage>–<lpage>606</lpage>.<pub-id pub-id-type="pmid">8893018</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0020">
<mixed-citation id="glia23730-cit-0020" publication-type="journal">
<string-name>
<surname>Henderson</surname>, <given-names>N. C.</given-names>
</string-name>, <string-name>
<surname>Mackinnon</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<surname>Farnworth</surname>, <given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Poirier</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Russo</surname>, <given-names>F. P.</given-names>
</string-name>, <string-name>
<surname>Iredale</surname>, <given-names>J. P.</given-names>
</string-name>, … <string-name>
<surname>Sethi</surname>, <given-names>T.</given-names>
</string-name> (<year>2006</year>). <article-title>Galectin‐3 regulates myofibroblast activation and hepatic fibrosis</article-title>. <source xml:lang="en"/>Proceedings of the National Academy of Sciences of the United States of America, <volume>103</volume>(<issue>13</issue>), <fpage>5060</fpage>–<lpage>5065</lpage>.<pub-id pub-id-type="pmid">16549783</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0021">
<mixed-citation id="glia23730-cit-0021" publication-type="journal">
<string-name>
<surname>Hillis</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Davies</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Mundim</surname>, <given-names>M. V.</given-names>
</string-name>, <string-name>
<surname>Al‐Dalahmah</surname>, <given-names>O.</given-names>
</string-name>, &amp; <string-name>
<surname>Szele</surname>, <given-names>F. G.</given-names>
</string-name> (<year>2016</year>). <article-title>Cuprizone demyelination induces a unique inflammatory response in the subventricular zone</article-title>. <source xml:lang="en"/>Journal of Neuroinflammation, <volume>13</volume>(<issue>1</issue>), <fpage>190</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1186/s12974-016-0651-2</pub-id>
<pub-id pub-id-type="pmid">27550173</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0022">
<mixed-citation id="glia23730-cit-0022" publication-type="journal">
<string-name>
<surname>Hirschhorn</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Levi‐Hofman</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Danziger</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Smorodinsky</surname>, <given-names>N. I.</given-names>
</string-name>, &amp; <string-name>
<surname>Ehrlich</surname>, <given-names>M.</given-names>
</string-name> (<year>2017</year>). <article-title>Differential molecular regulation of processing and membrane expression of type‐I BMP receptors: Implications for signaling</article-title>. <source xml:lang="en"/>Cellular and Molecular Life Sciences, <volume>74</volume>(<issue>14</issue>), <fpage>2645</fpage>–<lpage>2662</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-017-2488-y</pub-id>
<pub-id pub-id-type="pmid">28357470</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0023">
<mixed-citation id="glia23730-cit-0023" publication-type="journal">
<string-name>
<surname>Hoyos</surname>, <given-names>H. C.</given-names>
</string-name>, <string-name>
<surname>Rinaldi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Mendez‐Huergo</surname>, <given-names>S. P.</given-names>
</string-name>, <string-name>
<surname>Marder</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Rabinovich</surname>, <given-names>G. A.</given-names>
</string-name>, <string-name>
<surname>Pasquini</surname>, <given-names>J. M.</given-names>
</string-name>, &amp; <string-name>
<surname>Pasquini</surname>, <given-names>L. A.</given-names>
</string-name> (<year>2014</year>). <article-title>Galectin‐3 controls the response of microglial cells to limit cuprizone‐induced demyelination</article-title>. <source xml:lang="en"/>Neurobiology of Disease, <volume>62</volume>, <fpage>441</fpage>–<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.10.023</pub-id>
<pub-id pub-id-type="pmid">24184798</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0024">
<mixed-citation id="glia23730-cit-0024" publication-type="journal">
<string-name>
<surname>James</surname>, <given-names>R. E.</given-names>
</string-name>, <string-name>
<surname>Hillis</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Adorjan</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Gration</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Mundim</surname>, <given-names>M. V.</given-names>
</string-name>, <string-name>
<surname>Iqbal</surname>, <given-names>A. J.</given-names>
</string-name>, … <string-name>
<surname>Szele</surname>, <given-names>F. G.</given-names>
</string-name> (<year>2016</year>). <article-title>Loss of galectin‐3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis</article-title>. <source xml:lang="en"/>Glia, <volume>64</volume>(<issue>1</issue>), <fpage>105</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22906</pub-id>
<pub-id pub-id-type="pmid">26337870</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0025">
<mixed-citation id="glia23730-cit-0025" publication-type="journal">
<string-name>
<surname>Korchynskyi</surname>, <given-names>O.</given-names>
</string-name>, &amp; <string-name>
<surname>ten Dijke</surname>, <given-names>P.</given-names>
</string-name> (<year>2002</year>). <article-title>Identification and functional characterization of distinct critically important bone morphogenetic protein‐specific response elements in the Id1 promoter</article-title>. <source xml:lang="en"/>The Journal of Biological Chemistry, <volume>277</volume>(<issue>7</issue>), <fpage>4883</fpage>–<lpage>4891</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111023200</pub-id>
<pub-id pub-id-type="pmid">11729207</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0026">
<mixed-citation id="glia23730-cit-0026" publication-type="journal">
<string-name>
<surname>Lalancette‐Hebert</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Swarup</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Beaulieu</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Bohacek</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Abdelhamid</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Weng</surname>, <given-names>Y. C.</given-names>
</string-name>, … <string-name>
<surname>Kriz</surname>, <given-names>J.</given-names>
</string-name> (<year>2012</year>). <article-title>Galectin‐3 is required for resident microglia activation and proliferation in response to ischemic injury</article-title>. <source xml:lang="en"/>The Journal of Neuroscience, <volume>32</volume>(<issue>30</issue>), <fpage>10383</fpage>–<lpage>10395</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1498-12.2012</pub-id>
<pub-id pub-id-type="pmid">22836271</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0027">
<mixed-citation id="glia23730-cit-0027" publication-type="journal">
<string-name>
<surname>Levison</surname>, <given-names>S. W.</given-names>
</string-name>, <string-name>
<surname>Chuang</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Abramson</surname>, <given-names>B. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Goldman</surname>, <given-names>J. E.</given-names>
</string-name> (<year>1993</year>). <article-title>The migrational patterns and developmental fates of glial precursors in the rat subventricular zone are temporally regulated</article-title>. <source xml:lang="en"/>Development, <volume>119</volume>(<issue>3</issue>), <fpage>611</fpage>–<lpage>622</lpage>.<pub-id pub-id-type="pmid">8187632</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0028">
<mixed-citation id="glia23730-cit-0028" publication-type="journal">
<string-name>
<surname>Levison</surname>, <given-names>S. W.</given-names>
</string-name>, &amp; <string-name>
<surname>Goldman</surname>, <given-names>J. E.</given-names>
</string-name> (<year>1993</year>). <article-title>Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain</article-title>. <source xml:lang="en"/>Neuron, <volume>10</volume>(<issue>2</issue>), <fpage>201</fpage>–<lpage>212</lpage>.<pub-id pub-id-type="pmid">8439409</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0029">
<mixed-citation id="glia23730-cit-0029" publication-type="journal">
<string-name>
<surname>Li</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Lu</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Bandyopadhyay</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Oh</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Imamura</surname>, <given-names>T.</given-names>
</string-name>, … <string-name>
<surname>Olefsky</surname>, <given-names>J. M.</given-names>
</string-name> (<year>2016</year>). <article-title>Hematopoietic‐derived Galectin‐3 causes cellular and systemic insulin resistance</article-title>. <source xml:lang="en"/>Cell, <volume>167</volume>(<issue>4</issue>), <fpage>973</fpage>–<lpage>984</lpage> e912. <pub-id pub-id-type="doi">10.1016/j.cell.2016.10.025</pub-id>
<pub-id pub-id-type="pmid">27814523</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0030">
<mixed-citation id="glia23730-cit-0030" publication-type="journal">
<string-name>
<surname>Li</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Komai‐Koma</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Gilchrist</surname>, <given-names>D. S.</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>, <given-names>D. K.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>F. T.</given-names>
</string-name>, <string-name>
<surname>Springall</surname>, <given-names>T.</given-names>
</string-name>, &amp; <string-name>
<surname>Xu</surname>, <given-names>D.</given-names>
</string-name> (<year>2008</year>). <article-title>Galectin‐3 is a negative regulator of lipopolysaccharide‐mediated inflammation</article-title>. <source xml:lang="en"/>Journal of Immunology, <volume>181</volume>(<issue>4</issue>), <fpage>2781</fpage>–<lpage>2789</lpage>.</mixed-citation>
</ref>
<ref id="glia23730-bib-0031">
<mixed-citation id="glia23730-cit-0031" publication-type="journal">
<string-name>
<surname>Lim</surname>, <given-names>D. A.</given-names>
</string-name>, <string-name>
<surname>Tramontin</surname>, <given-names>A. D.</given-names>
</string-name>, <string-name>
<surname>Trevejo</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Herrera</surname>, <given-names>D. G.</given-names>
</string-name>, <string-name>
<surname>Garcia‐Verdugo</surname>, <given-names>J. M.</given-names>
</string-name>, &amp; <string-name>
<surname>Alvarez‐Buylla</surname>, <given-names>A.</given-names>
</string-name> (<year>2000</year>). <article-title>Noggin antagonizes BMP signaling to create a niche for adult neurogenesis</article-title>. <source xml:lang="en"/>Neuron, <volume>28</volume>(<issue>3</issue>), <fpage>713</fpage>–<lpage>726</lpage>.<pub-id pub-id-type="pmid">11163261</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0032">
<mixed-citation id="glia23730-cit-0032" publication-type="journal">
<string-name>
<surname>Liu</surname>, <given-names>F. T.</given-names>
</string-name>, &amp; <string-name>
<surname>Rabinovich</surname>, <given-names>G. A.</given-names>
</string-name> (<year>2005</year>). <article-title>Galectins as modulators of tumour progression</article-title>. <source xml:lang="en"/>Nature Reviews. Cancer, <volume>5</volume>(<issue>1</issue>), <fpage>29</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="pmid">15630413</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0033">
<mixed-citation id="glia23730-cit-0033" publication-type="journal">
<string-name>
<surname>Lois</surname>, <given-names>C.</given-names>
</string-name>, &amp; <string-name>
<surname>Alvarez‐Buylla</surname>, <given-names>A.</given-names>
</string-name> (<year>1994</year>). <article-title>Long‐distance neuronal migration in the adult mammalian brain</article-title>. <source xml:lang="en"/>Science, <volume>264</volume>(<issue>5162</issue>), <fpage>1145</fpage>–<lpage>1148</lpage>.<pub-id pub-id-type="pmid">8178174</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0034">
<mixed-citation id="glia23730-cit-0034" publication-type="journal">
<string-name>
<surname>Lopez</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>del Pozo</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Miguel</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Sastre</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Seoane</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Civantos</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Lahoz</surname>, <given-names>C.</given-names>
</string-name> (<year>2006</year>). <article-title>Inhibition of chronic airway inflammation and remodeling by galectin‐3 gene therapy in a murine model</article-title>. <source xml:lang="en"/>Journal of Immunology, <volume>176</volume>(<issue>3</issue>), <fpage>1943</fpage>–<lpage>1950</lpage>.</mixed-citation>
</ref>
<ref id="glia23730-bib-0035">
<mixed-citation id="glia23730-cit-0035" publication-type="journal">
<string-name>
<surname>Mabie</surname>, <given-names>P. C.</given-names>
</string-name>, <string-name>
<surname>Mehler</surname>, <given-names>M. F.</given-names>
</string-name>, <string-name>
<surname>Marmur</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Papavasiliou</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Song</surname>, <given-names>Q.</given-names>
</string-name>, &amp; <string-name>
<surname>Kessler</surname>, <given-names>J. A.</given-names>
</string-name> (<year>1997</year>). <article-title>Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial‐astroglial progenitor cells</article-title>. <source xml:lang="en"/>The Journal of Neuroscience, <volume>17</volume>(<issue>11</issue>), <fpage>4112</fpage>–<lpage>4120</lpage>.<pub-id pub-id-type="pmid">9151728</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0036">
<mixed-citation id="glia23730-cit-0036" publication-type="journal">
<string-name>
<surname>Matsuda</surname>, <given-names>T.</given-names>
</string-name>, &amp; <string-name>
<surname>Cepko</surname>, <given-names>C. L.</given-names>
</string-name> (<year>2004</year>). <article-title>Electroporation and RNA interference in the rodent retina in vivo and in vitro</article-title>. <source xml:lang="en"/>Proceedings of the National Academy of Sciences of the United States of America, <volume>101</volume>(<issue>1</issue>), <fpage>16</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2235688100</pub-id>
<pub-id pub-id-type="pmid">14603031</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0037">
<mixed-citation id="glia23730-cit-0037" publication-type="journal">
<string-name>
<surname>Mehler</surname>, <given-names>M. F.</given-names>
</string-name>, <string-name>
<surname>Mabie</surname>, <given-names>P. C.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>D.</given-names>
</string-name>, &amp; <string-name>
<surname>Kessler</surname>, <given-names>J. A.</given-names>
</string-name> (<year>1997</year>). <article-title>Bone morphogenetic proteins in the nervous system</article-title>. <source xml:lang="en"/>Trends in Neurosciences, <volume>20</volume>(<issue>7</issue>), <fpage>309</fpage>–<lpage>317</lpage>.<pub-id pub-id-type="pmid">9223224</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0038">
<mixed-citation id="glia23730-cit-0038" publication-type="journal">
<string-name>
<surname>Mercier</surname>, <given-names>F.</given-names>
</string-name>, &amp; <string-name>
<surname>Douet</surname>, <given-names>V.</given-names>
</string-name> (<year>2014</year>). <article-title>Bone morphogenetic protein‐4 inhibits adult neurogenesis and is regulated by fractone‐associated heparan sulfates in the subventricular zone</article-title>. <source xml:lang="en"/>Journal of Chemical Neuroanatomy, <volume>57‐58</volume>, <fpage>54</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchemneu.2014.03.005</pub-id>
</mixed-citation>
</ref>
<ref id="glia23730-bib-0039">
<mixed-citation id="glia23730-cit-0039" publication-type="journal">
<string-name>
<surname>Miller</surname>, <given-names>F. D.</given-names>
</string-name>, &amp; <string-name>
<surname>Gauthier</surname>, <given-names>A. S.</given-names>
</string-name> (<year>2007</year>). <article-title>Timing is everything: Making neurons versus glia in the developing cortex</article-title>. <source xml:lang="en"/>Neuron, <volume>54</volume>(<issue>3</issue>), <fpage>357</fpage>–<lpage>369</lpage>.<pub-id pub-id-type="pmid">17481390</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0040">
<mixed-citation id="glia23730-cit-0040" publication-type="journal">
<string-name>
<surname>Mira</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Andreu</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Suh</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Lie</surname>, <given-names>D. C.</given-names>
</string-name>, <string-name>
<surname>Jessberger</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Consiglio</surname>, <given-names>A.</given-names>
</string-name>, … <string-name>
<surname>Gage</surname>, <given-names>F. H.</given-names>
</string-name> (<year>2010</year>). <article-title>Signaling through BMPR‐IA regulates quiescence and long‐term activity of neural stem cells in the adult hippocampus</article-title>. <source xml:lang="en"/>Cell Stem Cell, <volume>7</volume>(<issue>1</issue>), <fpage>78</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">20621052</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0041">
<mixed-citation id="glia23730-cit-0041" publication-type="journal">
<string-name>
<surname>Mishina</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Hanks</surname>, <given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Miura</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Tallquist</surname>, <given-names>M. D.</given-names>
</string-name>, &amp; <string-name>
<surname>Behringer</surname>, <given-names>R. R.</given-names>
</string-name> (<year>2002</year>). <article-title>Generation of Bmpr/Alk3 conditional knockout mice</article-title>. <source xml:lang="en"/>Genesis, <volume>32</volume>(<issue>2</issue>), <fpage>69</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="pmid">11857780</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0042">
<mixed-citation id="glia23730-cit-0042" publication-type="journal">
<string-name>
<surname>Mizrak</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Levitin</surname>, <given-names>H. M.</given-names>
</string-name>, <string-name>
<surname>Delgado</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<surname>Crotet</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Chaker</surname>, <given-names>Z.</given-names>
</string-name>, … <string-name>
<surname>Doetsch</surname>, <given-names>F.</given-names>
</string-name> (<year>2019</year>). <article-title>Single‐cell analysis of regional differences in adult V‐SVZ neural stem cell lineages</article-title>. <source xml:lang="en"/>Cell Reports, <volume>26</volume>(<issue>2</issue>), <fpage>394</fpage>–<lpage>406</lpage> e395. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.12.044</pub-id>
<pub-id pub-id-type="pmid">30625322</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0043">
<mixed-citation id="glia23730-cit-0043" publication-type="journal">
<string-name>
<surname>Monje</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<surname>Toda</surname>, <given-names>H.</given-names>
</string-name>, &amp; <string-name>
<surname>Palmer</surname>, <given-names>T. D.</given-names>
</string-name> (<year>2003</year>). <article-title>Inflammatory blockade restores adult hippocampal neurogenesis</article-title>. <source xml:lang="en"/>Science, <volume>302</volume>(<issue>5651</issue>), <fpage>1760</fpage>–<lpage>1765</lpage>.<pub-id pub-id-type="pmid">14615545</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0044">
<mixed-citation id="glia23730-cit-0044" publication-type="journal">
<string-name>
<surname>Morell</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Tsan</surname>, <given-names>Y. C.</given-names>
</string-name>, &amp; <string-name>
<surname>O'Shea</surname>, <given-names>K. S.</given-names>
</string-name> (<year>2014</year>). <article-title>Inducible expression of noggin selectively expands neural progenitors in the adult SVZ</article-title>. <source xml:lang="en"/>Stem Cell Research, <volume>14</volume>(<issue>1</issue>), <fpage>79</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.scr.2014.11.001</pub-id>
<pub-id pub-id-type="pmid">25535864</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0045">
<mixed-citation id="glia23730-cit-0045" publication-type="journal">
<string-name>
<surname>Mutch</surname>, <given-names>C. A.</given-names>
</string-name>, <string-name>
<surname>Funatsu</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Monuki</surname>, <given-names>E. S.</given-names>
</string-name>, &amp; <string-name>
<surname>Chenn</surname>, <given-names>A.</given-names>
</string-name> (<year>2009</year>). <article-title>Beta‐catenin signaling levels in progenitors influence the laminar cell fates of projection neurons</article-title>. <source xml:lang="en"/>The Journal of Neuroscience, <volume>29</volume>(<issue>43</issue>), <fpage>13710</fpage>–<lpage>13719</lpage>.<pub-id pub-id-type="pmid">19864583</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0046">
<mixed-citation id="glia23730-cit-0046" publication-type="journal">
<string-name>
<surname>Nakajima</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Kho</surname>, <given-names>D. H.</given-names>
</string-name>, <string-name>
<surname>Yanagawa</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Harazono</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Gao</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Hogan</surname>, <given-names>V.</given-names>
</string-name>, &amp; <string-name>
<surname>Raz</surname>, <given-names>A.</given-names>
</string-name> (<year>2014</year>). <article-title>Galectin‐3 inhibits osteoblast differentiation through notch Signaling</article-title>. <source xml:lang="en"/>Neoplasia, <volume>16</volume>(<issue>11</issue>), <fpage>939</fpage>–<lpage>949</lpage>. <pub-id pub-id-type="doi">10.1016/j.neo.2014.09.005</pub-id>
<pub-id pub-id-type="pmid">25425968</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0047">
<mixed-citation id="glia23730-cit-0047" publication-type="journal">
<string-name>
<surname>Oyarce</surname>, <given-names>M. P.</given-names>
</string-name>, &amp; <string-name>
<surname>Iturriaga</surname>, <given-names>R.</given-names>
</string-name> (<year>2018</year>). <article-title>Contribution of oxidative stress and inflammation to the neurogenic hypertension induced by intermittent hypoxia</article-title>. <source xml:lang="en"/>Frontiers in Physiology, <volume>9</volume>, <fpage>893</fpage>
<pub-id pub-id-type="doi">10.3389/fphys.2018.00893</pub-id>
<pub-id pub-id-type="pmid">30050461</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0048">
<mixed-citation id="glia23730-cit-0048" publication-type="journal">
<string-name>
<surname>Partridge</surname>, <given-names>E. A.</given-names>
</string-name>, <string-name>
<surname>Le Roy</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Di Guglielmo</surname>, <given-names>G. M.</given-names>
</string-name>, <string-name>
<surname>Pawling</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Cheung</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Granovsky</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Dennis</surname>, <given-names>J. W.</given-names>
</string-name> (<year>2004</year>). <article-title>Regulation of cytokine receptors by Golgi N‐glycan processing and endocytosis</article-title>. <source xml:lang="en"/>Science, <volume>306</volume>(<issue>5693</issue>), <fpage>120</fpage>–<lpage>124</lpage>.<pub-id pub-id-type="pmid">15459394</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0049">
<mixed-citation id="glia23730-cit-0049" publication-type="journal">
<string-name>
<surname>Pasquini</surname>, <given-names>L. A.</given-names>
</string-name>, <string-name>
<surname>Millet</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Hoyos</surname>, <given-names>H. C.</given-names>
</string-name>, <string-name>
<surname>Giannoni</surname>, <given-names>J. P.</given-names>
</string-name>, <string-name>
<surname>Croci</surname>, <given-names>D. O.</given-names>
</string-name>, <string-name>
<surname>Marder</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Pasquini</surname>, <given-names>J. M.</given-names>
</string-name> (<year>2011</year>). <article-title>Galectin‐3 drives oligodendrocyte differentiation to control myelin integrity and function</article-title>. <source xml:lang="en"/>Cell Death and Differentiation, <volume>18</volume>(<issue>11</issue>), <fpage>1746</fpage>–<lpage>1756</lpage>.<pub-id pub-id-type="pmid">21566659</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0050">
<mixed-citation id="glia23730-cit-0050" publication-type="journal">
<string-name>
<surname>Ribeiro Xavier</surname>, <given-names>A. L.</given-names>
</string-name>, <string-name>
<surname>Kress</surname>, <given-names>B. T.</given-names>
</string-name>, <string-name>
<surname>Goldman</surname>, <given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Lacerda de Menezes</surname>, <given-names>J. R.</given-names>
</string-name>, &amp; <string-name>
<surname>Nedergaard</surname>, <given-names>M.</given-names>
</string-name> (<year>2015</year>). <article-title>A distinct population of microglia supports adult neurogenesis in the subventricular zone</article-title>. <source xml:lang="en"/>The Journal of Neuroscience, <volume>35</volume>(<issue>34</issue>), <fpage>11848</fpage>–<lpage>11861</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1217-15.2015</pub-id>
<pub-id pub-id-type="pmid">26311768</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0051">
<mixed-citation id="glia23730-cit-0051" publication-type="journal">
<string-name>
<surname>Rivkin</surname>, <given-names>M. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Volpe</surname>, <given-names>J. J.</given-names>
</string-name> (<year>1993</year>). <article-title>Hypoxic‐ischemic brain injury in the newborn</article-title>. <source xml:lang="en"/>Seminars in Neurology, <volume>13</volume>(<issue>1</issue>), <fpage>30</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">8511416</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0052">
<mixed-citation id="glia23730-cit-0052" publication-type="journal">
<string-name>
<surname>Sauvageot</surname>, <given-names>C. M.</given-names>
</string-name>, &amp; <string-name>
<surname>Stiles</surname>, <given-names>C. D.</given-names>
</string-name> (<year>2002</year>). <article-title>Molecular mechanisms controlling cortical gliogenesis</article-title>. <source xml:lang="en"/>Current Opinion in Neurobiology, <volume>12</volume>(<issue>3</issue>), <fpage>244</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1016/S0959-4388(02)00322-7</pub-id>
<pub-id pub-id-type="pmid">12049929</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0053">
<mixed-citation id="glia23730-cit-0053" publication-type="journal">
<string-name>
<surname>Shigemoto‐Mogami</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Hoshikawa</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Goldman</surname>, <given-names>J. E.</given-names>
</string-name>, <string-name>
<surname>Sekino</surname>, <given-names>Y.</given-names>
</string-name>, &amp; <string-name>
<surname>Sato</surname>, <given-names>K.</given-names>
</string-name> (<year>2014</year>). <article-title>Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone</article-title>. <source xml:lang="en"/>The Journal of Neuroscience, <volume>34</volume>(<issue>6</issue>), <fpage>2231</fpage>–<lpage>2243</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1619-13.2014</pub-id>
<pub-id pub-id-type="pmid">24501362</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0054">
<mixed-citation id="glia23730-cit-0054" publication-type="journal">
<string-name>
<surname>Sirko</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Irmler</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Gascon</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Bek</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Schneider</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Dimou</surname>, <given-names>L.</given-names>
</string-name>, … <string-name>
<surname>Gotz</surname>, <given-names>M.</given-names>
</string-name> (<year>2015</year>). <article-title>Astrocyte reactivity after brain injury‐: The role of galectins 1 and 3</article-title>. <source xml:lang="en"/>Glia, <volume>63</volume>(<issue>12</issue>), <fpage>2340</fpage>–<lpage>2361</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22898</pub-id>
<pub-id pub-id-type="pmid">26250529</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0055">
<mixed-citation id="glia23730-cit-0055" publication-type="journal">
<string-name>
<surname>Song</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Mazurek</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Sun</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Ding</surname>, <given-names>Q. Q.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>K.</given-names>
</string-name>, … <string-name>
<surname>Bresalier</surname>, <given-names>R. S.</given-names>
</string-name> (<year>2009</year>). <article-title>Galectin‐3 mediates nuclear beta‐catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase‐3beta activity</article-title>. <source xml:lang="en"/>Cancer Research, <volume>69</volume>(<issue>4</issue>), <fpage>1343</fpage>–<lpage>1349</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-4153</pub-id>
<pub-id pub-id-type="pmid">19190323</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0056">
<mixed-citation id="glia23730-cit-0056" publication-type="journal">
<string-name>
<surname>Srinivas</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Lin</surname>, <given-names>C.‐S.</given-names>
</string-name>, <string-name>
<surname>William</surname>, <given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Tanabe</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Jessell</surname>, <given-names>T. M.</given-names>
</string-name>, &amp; <string-name>
<surname>Costantini</surname>, <given-names>F.</given-names>
</string-name> (<year>2001</year>). <article-title>Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus</article-title>. <source xml:lang="en"/>BMC Developmental Biology, <volume>1</volume>(<issue>1</issue>), <fpage>4</fpage>
<pub-id pub-id-type="doi">10.1186/1471-213x-1-4</pub-id>
<pub-id pub-id-type="pmid">11299042</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0057">
<mixed-citation id="glia23730-cit-0057" publication-type="journal">
<string-name>
<surname>Sun</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Chang</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Gerhartl</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Szele</surname>, <given-names>F. G.</given-names>
</string-name> (<year>2018</year>). <article-title>Polycomb protein Eed is required for neurogenesis and cortical injury activation in the subventricular zone</article-title>. <source xml:lang="en"/>Cerebral Cortex, <volume>28</volume>(<issue>4</issue>), <fpage>1369</fpage>–<lpage>1382</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhx289</pub-id>
<pub-id pub-id-type="pmid">29415247</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0058">
<mixed-citation id="glia23730-cit-0058" publication-type="journal">
<string-name>
<surname>Tsai</surname>, <given-names>H. H.</given-names>
</string-name>, <string-name>
<surname>Li</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Fuentealba</surname>, <given-names>L. C.</given-names>
</string-name>, <string-name>
<surname>Molofsky</surname>, <given-names>A. V.</given-names>
</string-name>, <string-name>
<surname>Taveira‐Marques</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Zhuang</surname>, <given-names>H.</given-names>
</string-name>, … <string-name>
<surname>Rowitch</surname>, <given-names>D. H.</given-names>
</string-name> (<year>2012</year>). <article-title>Regional astrocyte allocation regulates CNS synaptogenesis and repair</article-title>. <source xml:lang="en"/>Science, <volume>337</volume>(<issue>6092</issue>), <fpage>358</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1126/science.1222381</pub-id>
<pub-id pub-id-type="pmid">22745251</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0059">
<mixed-citation id="glia23730-cit-0059" publication-type="journal">
<string-name>
<surname>Woodhead</surname>, <given-names>G. J.</given-names>
</string-name>, <string-name>
<surname>Mutch</surname>, <given-names>C. A.</given-names>
</string-name>, <string-name>
<surname>Olson</surname>, <given-names>E. C.</given-names>
</string-name>, &amp; <string-name>
<surname>Chenn</surname>, <given-names>A.</given-names>
</string-name> (<year>2006</year>). <article-title>Cell‐autonomous beta‐catenin signaling regulates cortical precursor proliferation</article-title>. <source xml:lang="en"/>The Journal of Neuroscience, <volume>26</volume>(<issue>48</issue>), <fpage>12620</fpage>–<lpage>12630</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3180-06.2006</pub-id>
<pub-id pub-id-type="pmid">17135424</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0060">
<mixed-citation id="glia23730-cit-0060" publication-type="journal">
<string-name>
<surname>Ying</surname>, <given-names>Q. L.</given-names>
</string-name>, <string-name>
<surname>Nichols</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Chambers</surname>, <given-names>I.</given-names>
</string-name>, &amp; <string-name>
<surname>Smith</surname>, <given-names>A.</given-names>
</string-name> (<year>2003</year>). <article-title>BMP induction of id proteins suppresses differentiation and sustains embryonic stem cell self‐renewal in collaboration with STAT3</article-title>. <source xml:lang="en"/>Cell, <volume>115</volume>(<issue>3</issue>), <fpage>281</fpage>–<lpage>292</lpage>.<pub-id pub-id-type="pmid">14636556</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0061">
<mixed-citation id="glia23730-cit-0061" publication-type="journal">
<string-name>
<surname>Young</surname>, <given-names>C. C.</given-names>
</string-name>, <string-name>
<surname>Al‐Dalahmah</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Lewis</surname>, <given-names>N. J.</given-names>
</string-name>, <string-name>
<surname>Brooks</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Jenkins</surname>, <given-names>M. M.</given-names>
</string-name>, <string-name>
<surname>Poirier</surname>, <given-names>F.</given-names>
</string-name>, … <string-name>
<surname>Szele</surname>, <given-names>F. G.</given-names>
</string-name> (<year>2014</year>). <article-title>Blocked angiogenesis in Galectin‐3 null mice does not alter cellular and behavioral recovery after middle cerebral artery occlusion stroke</article-title>. <source xml:lang="en"/>Neurobiology of Disease, <volume>63</volume>, <fpage>155</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.11.003</pub-id>
<pub-id pub-id-type="pmid">24269916</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0062">
<mixed-citation id="glia23730-cit-0062" publication-type="journal">
<string-name>
<surname>Young</surname>, <given-names>K. M.</given-names>
</string-name>, <string-name>
<surname>Fogarty</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Kessaris</surname>, <given-names>N.</given-names>
</string-name>, &amp; <string-name>
<surname>Richardson</surname>, <given-names>W. D.</given-names>
</string-name> (<year>2007</year>). <article-title>Subventricular zone stem cells are heterogeneous with respect to their embryonic origins and neurogenic fates in the adult olfactory bulb</article-title>. <source xml:lang="en"/>The Journal of Neuroscience, <volume>27</volume>(<issue>31</issue>), <fpage>8286</fpage>–<lpage>8296</lpage>.<pub-id pub-id-type="pmid">17670975</pub-id></mixed-citation>
</ref>
<ref id="glia23730-bib-0063">
<mixed-citation id="glia23730-cit-0063" publication-type="journal">
<string-name>
<surname>Zhang</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Qin</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Cong</surname>, <given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Shao</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Du</surname>, <given-names>Z.</given-names>
</string-name>, … <string-name>
<surname>Ding</surname>, <given-names>K.</given-names>
</string-name> (<year>2017</year>). <article-title>RN1, a novel galectin‐3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin‐3 associated signaling pathways</article-title>. <source xml:lang="en"/>Oncogene, <volume>36</volume>(<issue>9</issue>), <fpage>1297</fpage>–<lpage>1308</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2016.306</pub-id>
<pub-id pub-id-type="pmid">27617577</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>